The Congress Management Committee is pleased to announce the following confirmed invited speakers:

Prof-John-Aaskov (300x200) 

Professor John Aaskov  (Australia)

Professor John Aaskov is a Virologist at the Queensland University of Technology and Director of a WHO Collaborating Centre for Arbovirus Reference and Research. He has been involved in the development of tests for the diagnosis of common mosquito-borne viral diseases and the vaccines to prevent them. His current research interests focus on the population dynamics of arthropod-borne viruses and how these might be manipulated to support disease control processes, including immunisation and vector control. He also has worked extensively in the Asia Pacific region on diagnostic laboratory strengthening projects. 

 Sam Abraham

Dr Sam Abraham  (Australia) 

Dr. Sam Abraham is a Lecturer in Microbiology at Murdoch University. His is an early career researcher with an interest in antimicrobial resistance among zoonotic bacterial pathogens. 

KAsiedu_photo 

Dr Kingsley Asiedu  (Switzerland) 

Dr Kingsley Asiedu received his MD from the University of Science and Technology Kumasi, Ghana in 1990. After completing his rotations at the Komfo Anokye Teaching Hospital in Kumasi, he started his career in public health in 1993 in the remote rural district of Amansie West, one of the country’s most deprived areas. From 1996 to 1997, he earned a public health degree with a focus on health policy and management at the Rollins School of Public Health, Emory University, Atlanta, United States of America. He joined the World Health Organization in 1998 as a medical officer responsible for Buruli ulcer. He is currently responsible for two neglected tropical diseases – Buruli ulcer and yaws – in the Department of Control of Neglected Tropical Diseases (NTDs). His interests include district health systems, health policy, communicable diseases control, integrated control and management of skin NTDs and operational research. 

Allauzen_Picture

Dr Sophie Allauzen   (United States of America)

Sophie Allauzen is a Senior Program Officer (SPO) for Global Health Diagnostics at the Bill and Melinda Gates foundation (BMGF).  Her main interest is to explore innovate diagnostic approaches to solving health problems in the context of the developing world. She is currently overseeing the malaria diagnostic program working with various selected partner institutions to develop novel diagnostic tools to support the BMGF overall malaria strategy for malaria eradication termed “Accelerate to Zero”.

Sophie’s background includes 15 years of international experience in R&D, business development, and portfolio management. Prior joining BMGF, she worked at Novartis Diagnostics, Bio-Rad and Sanofi Diagnostics Pasteur. She holds a PhD in Biochemistry/Immunology from the University of Montpellier, France, directed toward auto-immune disease mechanisms, and held a Postdoc fellow position in Allergy at the University of Minnesota.

KBaird

Professor Kevin Baird  (Indonesia)

Professor Baird earned a B.Sc. in Microbiology and a M.Sc. in Biochemistry from University of Maryland in 1980 and 1983, and a Ph.D. in Medical Zoology from Tulane University School of Public Health and Tropical Medicine in 1994. He began working on malaria at the Division of Experimental Therapeutics at Walter Reed Army Institute of Research in 1981, and joined the US Navy Medical Service Corps in 1984.  Over the next 22 years he served four tours of duty at US Naval Medical Research Unit #2 in Jakarta, Indonesia, along with assignments to Philippines, Ghana, Peru and Washington, DC. Since 2007 Prof. Baird has directed the Eijkman-Oxford Clinical Research Unit in Jakarta on behalf of Oxford University, where he is Professor of Malariology in the Nuffield Department of Medicine. Prof. Baird is an internationally acknowledged expert on the prevention, control, treatment, and epidemiology of Plasmodium vivax malaria. He serves on several committees, working groups, and review groups at the World Health Organization’s Global Malaria Program. In 2005 the American Society of Tropical Medicine & Hygiene awarded him the Bailey K. Ashford Medal in recognition of distinguished work in the field of tropical medicine.

 photo-md-bargues-ictmm

Dr Maria Dolores Bargues  (Spain) ASP Speaker

Chair Professor of Parasitology, Director of the Molecular Biology Research Unit of the Department of Parasitology, University of Valencia, Spain, Deputy Director in the WHO Collaborating Centre on Fascioliasis and Its Snail Vectors, and in the FAO-United Nations Reference Centre for Parasitology. Project research responsible (PI) in the Excellence Network of Tropical Disease Centers of Spain (RICET).

Her research has mainly focused on molecular epidemiology of: fascioliasis and its lymnaeid snail vectors worldwide, planorbid snail vectors of schistosomiasis, triatomine insects transmitting Chagas disease in Latin America, culicid vectors of medical importance, and malaria transmission risk and spread in Europe and the likely impact of environment, human behaviour and climate changes on these parasitic diseases. Her team has more than 22 years experience on molecular techniques applied to disease vectors and parasite species. She has been a member of several International Networks (ECLAT, CDIA, EDEN), and has large expertise in leading projects of the European Commission and other projects with international and national funding.

She held several national and in international advisory and consultancy positions and has received prizes and awards for her outstanding results in research.

QBassat

Dr Quique Bassat  (Spain)

As a pediatrician, with special interest in infectious disease epidemiology and public health, Dr. Bassat has attempted to combine his clinical work with biomedical research in those diseases that most affect the poor and vulnerable. Originally based in Manhiça, Mozambique, he worked there as a pediatrician and a clinical researcher, participating in different clinical trials related to malaria prevention and treatment, such as the different RTS,S malaria candidate vaccine clinical trials (infant and older children studies). He also led the Manhiça part of different phase III multicentre antimalarial drug studies that were decisive for the clinical development of new antimalarial drugs (dihydroartemisinin-piperaquine; dispersable artemether-lumefantrine). He was also particularly interested in the study of the burden, trends and characterization of malaria in children admitted to hospital, and the overlapping symptomatology between malaria and other common infectious diseases. While his work was initially focused in P. falciparum malaria and children, he has widened his scope of interest to the study of Plasmodium vivax. In recent years, in addition to the ongoing work in Mozambique, he has coordinated the implementation of various P. vivax related studies in countries such as Brazil, India or Papua New Guinea, aiming to describe in greater depth the epidemiology and clinical manifestations related to this species. Such work has included the first fully-characterized large series of P. vivax severe cases collected from two very distinct countries (Brazilian Amazon and India’s Rajasthan) following an identical protocol, and the first series of P. vivax associated deaths fully studied through complete autopsy. In recent years, he has also spent important efforts describing the epidemiology and control of Yaws in Papua New Guinea. He has also conducted work on the description of the epidemiology and etiology of respiratory infections (viral and bacterial) both in Mozambique and in Morocco.

Currently, his main project is related to the validation and implementation of Minimally Invasive Autopsy (MIA) tools for the post-mortem investigation of Causes of death in the developing world.

 square_Leadership_headshots_James_Beeson_2013_210_x_210

Professor James Beeson  (Australia) 

An ARC and NHMRC research fellow, and a public health physician, Professor Beeson completed his medical degree at Monash University in 1992. Based at The Walter and Eliza Hall Institute of Medical Research, with field work at the Queen Elizabeth Central Hospital and Wellcome Trust Clinical Research Program, Malawi, his thesis titled ‘Mechanisms of placental infection by Plasmodium falciparum,’ was passed through the University of Melbourne. This work has highlighted the challenge of improving maternal health in resource-poor countries with a high burden of disease, emphasising the need for programs and interventions that address multiple causes of poor maternal health rather than specific diseases in isolation.

Following specialty training as a public health physician in 2001, he headed a research group at the Walter and Eliza Hall Institute from 2004-2010. In January 2011 he joined the Burnet Institute.

Professor Beeson has worked in malaria research in Africa and Asia for 15 years, including Malawi, Kenya, Papua New Guinea and Thailand. His research group primarily focuses on understanding how malaria causes disease in people and how immunity to malaria develops, and on the development of interventions to reduce malaria, such as vaccines or public health programs.

 Amalia_Berna

Dr Amalia Berna (Australia)

Amalia Z. Berna is a Senior Research Scientist at CSIRO. She received her PhD degree in Applied Biological Science from Catholic University of Leuven, Belgium. Amalia leads the volatile biomarker discovery component of the Innovative Bioproducts group, her research focuses on the detection of low abundance volatiles released above food, plants and in human’s breath, with the aim of providing faster tools for predicting quality and health. Amalia have developed and validated state-of-the-art methods for capturing, stabilizing, storing and transporting human breath for gas chromatography-mass spectrometry analysis. Her current research work is investigating chemicals in human breath that can indicate an individual’s health (with respect to infectious or non-infectious diseases), metabolic status or food intake. Her most successful and innovative example in this area is the discovery of volatile chemical biomarkers (thioethers) in the breath of individuals with experimental malaria infections. Using these biomarkers it may be possible to develop improved malaria tests using patients’ expired breath. Amalia is author of over 26 refereed international journal papers with >500 life citations and inventor of two patent families.

 Dbisanzio-web

Dr Donal Bisanzio  (United Kingdom) 

Dr. Donal Bisanzio is a veterinarian epidemiologist. His research is focused on the study of vector-borne and parasitic diseases in humans and animals with major public health impact. His multi-disciplinary research projects have included studies of West Nile virus in the USA and Italy, Lyme disease in Italy, malaria and poly-parasitism in Kenya, Dengue in Brazil and Peru, and leprosy in Brazil. Donal’s studies are performed using field and satellite data, results of laboratory studies, and sophisticated statistical/mathematical analyses to construct static and dynamic models to identify risk factors for the introduction, persistence, and spread of vector-borne and parasitic infections. Donal is now a Senior Postdoctoral Modeller at the Malaria Atlas Project group (MAP), Oxford University (Oxford, UK) working on changing patterns of malaria burden in Africa.

 MBoyd

Professor Mark Boyd  (Australia)

Mark Boyd is the founding Chair of Medicine at the Lyell McEwin Hospital in Adelaide, South Australia. He is a Professor of Medicine, a Senior Australian NHMRC Fellow, the current President of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) and co-Editor-in-Chief of the open access journal AIDS Research and Therapy. In the past 5 years Professor Boyd has led a set of major international, multi-centre randomised controlled trials sponsored by the Kirby Institute at the University of New South Wales. Both have answered clinical questions of major importance in the use of combination antiretroviral therapy worldwide. The robust results of both studies have been incorporated into the most recently updated WHO guidelines for the use of HIV therapy in adults and adolescents. In 2014 Professor Boyd was awarded the prestigious Frank Fenner Prize for Advanced Research in Infectious Diseases by the Australasian Society for Infectious Diseases.

 rbrady

Dr Robyn Brady  (Australia) 

Robyn Brady was the first Queensland dual qualified paediatrician/ emergency specialist and has influenced a whole generation of paediatric and emergency trainees to become more observant, metacognitive, and family oriented in their Paediatric Emergency Medicine (PEM) interactions. She introduced scenario-based training, and helped bring Advanced Paediatric Life Support to New Zealand, Vietnam and Russia. Currently based at Lady Cilento Children’s Hospital in Brisbane, she co-chairs the PEM Point-of-care Ultrasound (POCUS) ANZ group and is passionate about ultrasound as the ‘third eye’ for physicians of the 21st century. This passion has taken her to Cuba, Torres Straits and Timor Leste as a volunteer, teacher, and ultrasound wielding physician. Dr Brady will speak about ultrasound utility and possible ultrasound skilling pathways for practitioners in resource limited tropical medicine settings.

J.Burrows

Dr Jeremy Burrows   (Switzerland)

Dr Jeremy Burrows,  VP, Head of Drug Discovery at Medicines for Malaria Venture (MMV).  Jeremy obtained a MA in chemistry and a D.Phil. in synthetic organic chemistry at Oxford University (1989-1996).   In 1997 he joined ZENECA/ AstraZeneca as a medicinal chemist working in Infection, Cardiovascular and Inflammation research in the UK.  In 2005 he was seconded to Sweden in CNS/Pain where he led a section focused on Alzheimer’s disease.  In 2008, he joined MMV where he is VP Head of Drug Discovery overseeing a growing portfolio of enabling technology, screening, Hit-to-lead and Lead Optimisation projects both with academic and industrial partners.  He sits on the advisory committees for several external drug discovery collaborations and regularly reviews articles and grant proposals within the neglected disease area.  In 2013 he became a Fellow of the Royal Society of Chemistry.

 

Dr Jun Cao  (China)  WHO/TDR Sponsored Speaker  

Dr. Jun Cao is Professor at Jiangsu Institute of Parasitic Diseases (JIPD), PR. China, standing committee Member & secretary of Jiangsu Society of Preventive Medicine Parasitology Committee. He started his career of malaria control/elimination and research in Jiangsu Province since 2000. At present, he severs as the Deputy Director in JIPD, carrying out scientific research on malaria and other parasitic diseases, mainly interested in epidemiology, diagnosis, drug-resistant, parasite and host interaction, which provide better understanding on the parasite and evidence for control/elimination. Since JIPD provides technical training not only for local technicians, but also for international health workers from Africa and South East Asia, more than 30 international training courses held and over 1000 participants were trained in JIPD. He served as one of instructors, has more than 15 years’ experience for training organization and teaching. 

VM Cao-Lormeau_web 

Dr Van-Mai Cao-Lormeau  (French Polynesia)

Dr Cao-Lormeau, PhD, is a senior research scientist at the Institut Louis Malardé (ILM), French Polynesia. She has been leading research on arboviruses, notably dengue, chikungunya and Zika viruses, from 2007. She has been the principal investigator of many projects interested in surveillance, epidemiology, molecular epidemiology and prevalence of arboviruses in Pacific Islands Countries, with a particular focus on French Polynesia and Fiji. With the support of WHO, Division of Pacific Technical Support, she coordinated ILM contributions’ to “Acute Fever and Rash” outbreak investigations in several Pacific islands. She contributed to the laboratory investigations related to the Zika outbreak in French Polynesia and she leaded the ones allowing establishing the link between Guillain Barré Syndrome and Zika virus infection.

JCarapetis

Professor Jonathan Carapetis  (Australia) 

Professor Carapetis is the Director of the Telethon Kids Institute in Perth, Western Australia. He holds separate qualifications as a medical practitioner (MBBS), specialist paediatrician (FRACP Paediatrics), specialist infectious diseases physician (FRACP Infect Dis), and specialist public health physician (FAFPHM), as well as a PhD.

He is recognised as a leading mind in the Australian health field, with particular expertise in Indigenous child health. Professor Carapetis was the Director of the Menzies School of Health Research in Darwin from 2006-2012 where he forged new directions in research and training to tackle the big problems in Indigenous health. Amongst his many accolades, Professor Carapetis was awarded a Distinguished Honorary Fellow from the Menzies School of Health Research in 2015, an Honorary Doctor of Science from Charles Darwin University in 2013 and named as Northern Territory Australian of the Year for 2008. He has been named as one of Australia’s top 100 brains in Cosmos magazine, selected in the top ten in Medicine and Health in the Bulletin Magazine’s “Smart 100” list, and attended the Prime Minister’s 20:20 summit in Canberra in 2008.

Professor Carapetis has made an international contribution and commitment to the reduction of rheumatic heart disease. While rare in most developed countries, Australia has one of the highest rates of the disease in the world due to its prevalence within Aboriginal and Torres Strait Islander communities, particularly in Northern Australia. Professor Carapetis undertook his medical training at the Royal Melbourne and Royal Children’s Hospitals.

Previous positions include terms as Director of the Centre for International Child Health at the University of Melbourne, Theme Director at the Murdoch Children’s Research Institute in Melbourne and Clinical Fellow in Paediatric Infectious Diseases at the Hospital for Sick Children, Toronto, Canada. Professor Carapetis holds a clinical position with the Princess Margaret Hospital for Children and is a Professor at the University of Western Australia.

 LChai_web

Dr. Yi Ann Louis Chai  (Singapore)

Dr. Yi Ann Louis Chai is Senior Consultant Infectious Diseases Physician, University Medicine Cluster, National University Health System, Singapore, and Principal Investigator, Opportunistic Infections Group, Division of Infectious Diseases, NUHS.

He attained his medical degree from National University of Singapore in 1997 and MRCP(UK) in 2003. In 2010, he obtained his PhD from Radboud University, Nijmegen, the Netherlands. Dr Chai is recipient of the Clinician Scientist Award in 2011 and 2016. He is funded by the National Medical Research Council of Singapore and the National University Health System.

Dr Chai’s interests lie in opportunistic and atypical infections in immunocompromised hosts, patients with altered immunity and host-pathogen interaction. These are also the themes of his research group. He remains deeply entrenched at the bedside in providing clinical service for general infectious diseases and internal medicine.

 QCheng_web

Dr Qin Cheng  (Australia)

Dr Qin Cheng studied public health medicine (BMed) and completed Masters (MMed) in 1985.  After completing a PhD in 1993, Dr Cheng conducted biomedical research on malaria parasites and vaccines at the Queensland Institute of Medical Research (QIMR).  Dr Cheng has been Head of the Drug Resistance and Diagnostics Department at the Australian Army Malaria Institute (AMI) since 1998.  She has also been a visiting scientist at QIMR since 1998 and was Head of Malaria Drug Resistance and Chemotherapy Laboratory at QIMR between 2000 and 2010.  Dr Cheng had a joint appointment as Associate Professor at the Faculty of Health Sciences, University of Queensland between 2004 and 2015. 

Dr Cheng’s laboratory investigates mechanisms and evolution of drug resistance in malaria parasites, new diagnostics, parasite biology and molecular epidemiology of malaria in support of ADF and public health.  Over the past 15 years, her lab has made significant contributions to elucidating mechanisms of chloroquine, atovaqone, pyrimethamine and sulfadoxine resistance in malaria parasites.  Currently, the laboratory is investigating artemisinin-induced dormancy and its role in artemisnin resistance.  The laboratory has also conducted operational orientated research playing an important role in the WHO-FIND Malaria Rapid Diagnostic Tests Evaluation Program, the WHO Pacific Malaria Drug Resistance Monitoring Network, the Pacific Malaria Initiative and the Asia-Pacific Malaria Elimination Network.

 O-Chosidow

Professor Olivier Chosidow (France) 

Olivier Chosidow is Professor and head of the Department of Dermatology at the University Paris-est Creteil Val de Marne Teaching Hospital Henri Mondor, Créteil, France. Dermatologist since 1987, he obtained his PhD in pharmacology in 1995 and graduated in clinical epidemiology in 1997. He is involved in EBM (including the position of co-director of the French satellite of the Cochrane Skin Group), skin Infectious Diseases, including necrotizing fasciitis and scabies, Internal Medicine and Severe Cutaneous Adverse Reactions to Drugs.

To date, he has authored more than 400 primary and review articles, including NEJM, Lancet, BMJ, JAMA, … He served as assistant section editor in the JAMA Dermatology (2009-2014) and belong to the editorial boards of JAAD (2008-2013). He wrote several chapters in text-books including ‘Evidence-based Dermatology’ and ‘Rook’s Arthropods chapter’.

He is involved in both Clinical research Unit (EpiDermE for Epidemiology in Dermatology and Evaluation of Therapeutics) and Parasitological lab at the EnVA (The French vet school) with both dermatologists and parasitologists. He was President of the French Society of Dermatology in 2013-2014, belongs to the EADV, ESDR and AAD Societies and is member of the IACS (International Alliance for the Control of Scabies) Steering Committee. 

 Chibale_web

Professor Kelly Chibale  (South Africa) MMV Special Symposium Speaker  

Kelly Chibale is a full Professor of Organic Chemistry at the University of Cape Town (UCT) in South Africa. At UCT he is also Full Member of the Institute of Infectious Disease & Molecular Medicine, Tier 1 South Africa Research Chair in Drug Discovery, Director of the South Africa Medical Research Council Drug Discovery Research Unit and Director of the Drug Discovery and Development Centre (H3D).

Kelly obtained his PhD in Synthetic Organic Chemistry from the University of Cambridge in the UK with Stuart Warren (1989-1992).  This was followed by postdoctoral stints at the University of Liverpool in the UK as a British Ramsay Research Fellow with Nick Greeves (1992-94) and at the Scripps Research Institute in the USA as a Wellcome Trust International Prize Research Fellow with K.C. Nicolaou (1994-96). He was a Sandler Sabbatical Fellow at the University of California San Francisco in the USA (2002), a US Fulbright Senior Research Scholar at the University of Pennsylvania School of Medicine in the USA (2008) and a Visiting Professor at Pfizer in the UK (2008). His research is in the field of antimalarial drug discovery.

 A_Clements

Professor Archie Clements (Australia)

Archie Clements directs the Research School of Population Health, at The Australian National University, Canberra. He was previously Professor of Infectious Disease Epidemiology at the University of Queensland, and has worked as Research Fellow at the Schistosomiasis Control Initiative (SCI), Imperial College London, UK. He is also a current NHMRC Senior Research Fellow and head of the Global Health Group at ANU-RSPH. Professor Clements has over 10 years of experience in epidemiological research, with a particular emphasis on improving the efficiency and effectiveness of public health interventions for a range of infectious diseases including; parasitic diseases; mosquito-borne diseases; and emerging healthcare-acquired infections. This has included: (i) authoring 148 peer-reviewed papers; (ii) currently supervising 13 PhD students (iii) winning competitive grant funding worth $19.8M ($5.4 as CIA/principal investigator).

Ian Cockburn_web2 

Associate Professor Ian Cockburn  (Australia)  

Ian Cockburn received his PhD in 2005 from the University of Edinburgh for work on understanding host resistance to malaria. He found that individuals in Papua New Guinea were protected against severe disease due to a lack of complement receptor 1 on their red blood cells. This deficiency made the red blood cells less susceptible to invasion and less likely to form pathogenic clumps called “rosettes”. Subsequently he was a post-doctoral fellow in the laboratory of Fidel Zavala at Johns Hopkins University. There he made a number of breakthroughs in our understanding of how CD8+ T cells protect against Plasmodium liver stages, including the first intra-vital imaging of pathogen killing by these cells. In 2013 he moved to  the Australian National University in Canberra where his laboratory focusses on understanding how to generate protective B cell responses to the Plasmodium sporozoite.

 DCoelho (200x300)

Dr Danina Coelho  (Timor Leste)

Danina Coelho was qualified from Universidade do Porto Portugal in 2003, become consultant in 2011. She joint Centro Hospitalar São João do Porto until 2013. Return back to Timor Leste in 2014 and work as Clinical Advisor for Hospital Nacional Guido Valadares. Her duty include advice hospital council of director to establish policy and standard for hospital services. Also provide expertise in clinical setting and running several in house training for young doctor in issue related to management of infectious diseases patient. She establishes Hepatitis Clinic in 2015. She was a chairman of medical record committee and Infection prevention and control committee in 2014 & 2015. Appointed by Honorary Ministry of Health as president of Steering Committee for Pathology Development Program. Currently she is work in Ministry of Health as advisor for Health Quality and Control with main duty of setting up standard for quality health services in Timor Leste. She is a member of European Society of Infectious Diseases and Clinical Microbiology, Member of International Society for Infectious Diseases, Member of Portuguese Society for Infectious Diseases, Member of Portuguese Society for Hospital Management and Member of Australasian Society for Infectious Diseases, Core Member of National Immunization Technical Advisory Groups for Timor Leste, Core Member of Task Force on Antimicrobial Resistance for Timor Leste.

 Vincent Corbel

Dr Vincent Corbel   (Thailand)

Dr Vincent Corbel is Research Professor at Institut de Recherche pour le Développement (IRD), France and adjunct professor at the Department of Entomology, Kasetsart University, Bangkok, Thailand. He has longstanding research experience on vectors of human diseases (malaria, dengue, chikungunya) and their control. He has led several research and training programmes in medical entomology in French oversea departments (2004-2008), Africa (2008-2012) and South East Asia (2012-2016) and he is coordinating since 2012 the WHO collaborating centre for testing and evaluation of public health pesticides in South East Asia (Vector Biology & Control Network). His research activities focus on vector control, vector biology & ecology and insecticide resistance. He chairs the working group of the WHO Pesticide Evaluation Scheme since 2014 and is a member of the RBM Vector Control Group since 2008. He is currently leading an international research unit (STOPVEC) at the department of Entomology, Kasetsart University, Thailand.

 FCosta

Dr Federico Costa  (Brazil)

Federico Costa is an infectious disease epidemiologist interested in developing research programs and community-level interventions that address the zoonotic diseases which have emerged in marginalized slum settlements (i.e. leptospirosis and dengue). He is conducting interdisciplinary evaluations of disease hosts, pathogens, and environmental determinants of urban poverty in order to understand the intensity of zoonosis epidemics. He leads the field implementation of several large NIH, Wellcome Trust and Brazilian Ministry of Health-supported epidemiological studies for the past several years.

A Cowman

Professor Alan Cowman   (Australia)

Professor Alan Cowman is Head of the Division of Infection and Immunity at the Walter and Eliza Hall Institute of Medical Research. He is Head of the Division of Infection and Immunity at the Walter and Eliza Hall Institute of Medical Research. He is a Fellow of the Australian Academy of Sciences and the Royal Society and has received a number of awards including the Glaxo Award for Advanced Research in Infectious Diseases, Gottschalk Medal for Medical Science and Biology from the Australian Academy of Sciences, Boehringer-Mannheim Medal, Glaxo-Wellcome Australia Medal and the Howard Taylor Ricketts Medal from the University of Chicago. He has also received the Victoria Prize from the Victorian Government as well as the Mahathir Science Prize from the Mahathir Science Award Foundation (Malaysia). He has over 290 research publications mainly in the area of malaria biology.

His work is aimed at understanding the function of proteins in Plasmodium falciparum, the causative agent of the most severe form of malaria in humans and to use this information for the development of vaccines and drug targets against this parasitic disease.

Peter Crompton, WEB

Professor Peter Crompton  (United States of America)  ASP Sponsored Speaker 

Peter Crompton received his M.D. and M.P.H. from the Johns Hopkins Schools of Medicine and Public Health in 2000. He then completed an internal medicine residency at Massachusetts General Hospital before going on to an infectious disease fellowship at NIAID/NIH in 2004 where he joined the Laboratory of Immunogenetics to pursue his research interest in the human immune response to malaria. In 2010, he became a tenure-track investigator and chief of the Malaria Infection Biology & Immunity Unit at NIAID/NIH. In collaboration with an outstanding team of scientists and clinicians at the University of Bamako in Mali, he conducts cohort studies to investigate the cellular and molecular basis of naturally acquired immunity to malaria.

 P_Cunningham_1

Mr Philip Cunningham (Australia) 

Philip Cunningham is the Chief Operating Officer and Senior Scientist at the NSW State Reference Laboratory for HIV at St Vincent’s Hospital in Sydney. The laboratory was established in 1982 and plays an essential role in public health surveillance to monitor trends, evaluate interventions and provide early warning of changing patterns of HIV infection in Australia. He has developed and implemented testing strategies focused on diagnosis of recent HIV infection. He has led a number of local and international licensing studies for a range of tests for infectious diseases including point-of-care tests. He has implemented laboratory quality management programs with the goal of accreditation in resource constrained settings in South East Asia and the Western Pacific. These expanding programs have supported the wider availability of antiretroviral treatments in these countries.

Philip is actively engaged in public health research involving surveillance of target priority populations at risk of HIV and other sexually transmitted infections.  Recently his research interests have focused on improving access to HIV testing at the point of care and monitoring through sustainable and quality pathways aimed at increasing demand for testing in hard to reach populations that may be of risk of infection. Philip is immediate past Vice President of the Australasian Society of HIV Medicine (ASHM), is co-chair on the National HIV Testing Policy review and Expert Reference Group for the NSW Ministry of Health panel for HIV POCT. He is a visiting senior research fellow at the Kirby Institute at the University of New South Wales and is the Chief Operating Officer for the St Vincent’s Centre for Applied Medical Research.

 Bart Currie_web

Professor Bart Currie  (Australia) 

Bart Currie is an infectious diseases and public health physician at Royal Darwin Hospital and Professor in Medicine at the Northern Territory Medical Program, Flinders and Charles Darwin Universities. He is also Program Leader for Tropical and Emerging Infectious Diseases in the Global and Tropical Health Division of the Menzies School of Health Research and Director of the National Coordinating Unit for acute rheumatic fever and rheumatic heart disease (RHD Australia). Areas of interest include clinical and epidemiological aspects of tropical and emerging infections, development of treatment guidelines and clinical toxinology.

 

Dr Alexandre J. da Silva   (United States of America)

Dr Alexandre J. da Silva is the Lead Parasitologist for the U.S. FDA’s Center for Food Safety and Applied Nutrition, Office of Applied Research and Safety Assessment. Dr. Da Silva has more than 20 years of experience in parasitology and authored and co-authored more than 100 publications in the field of diagnostic parasitology, molecular biology, parasite biology, genomics applied to parasitology, pathogen discovery and epidemiology of parasitic diseases. Before joined the U.S. FDA he spent more than 20 years working at the Center for Disease Control and Prevention and for many years  Lead the Laboratory Diagnostic Program known as DPDx.

 DDance_web

Dr David Dance  (United Kingdom)

After qualifying in medicine at the University of Bristol, David Dance trained as a Medical Microbiologist with the Public Health Laboratory Service in the UK, before spending 4 years in Thailand with the Wellcome-Mahidol University-Oxford Tropical Medicine Research Programme. In 1986 he helped to establish studies of melioidosis in Ubon Ratchathani, northeast Thailand, that are still ongoing.  He spent 4 years as Senior Lecturer at the London School of Hygiene and Tropical Medicine continuing research on melioidosis and other tropical infections in Asia and Tanzania, and acting as Course Organiser for the MSc in Medical Microbiology.  In 1994 he returned to clinical microbiology practice as Director of Plymouth Public Health Laboratory, and in 2004 he became Regional Microbiologist (South West), but he maintained an interest in melioidosis, latterly both as a cause of imported infections in the UK, but also as a potential bioweapon.  He also served on the national Councils of the British Infection Society, Association of Medical Microbiologists, and Royal College of Pathologists.

In 2010 he returned to SE Asia to continue research on tropical bacterial infections, including melioidosis, in the Lao Peoples’ Democratic Republic as part of the Oxford University Tropical Network. His current role combines research with an advisory role in the Microbiology laboratory and clinical consultation service in Mahosot Hospital, Vientiane. He has published more than 100 peer-reviewed papers, correspondence and book chapters on melioidosis, particularly clinical aspects, epidemiology, diagnosis, antimicrobial susceptibility and treatment.

 2015-10-12 13.37.10._retoque

Professor Cláudio Tadeu Daniel-Ribeiro  (Brazil) 

Professor Cláudio Tadeu Daniel-Ribeiro graduated in Medicine in Rio de Janeiro (1976) and got his Phd from the Université Pierre et Marie Curie (Paris VI), in 1983. He is Full Researcher and Professor of the Instituto Oswaldo Cruz (IOC) – Fiocruz, where he heads the Center for Research, Diagnostics and Training on malaria which is a Reference Laboratory at the Ministry of Health. He is Member of the National Brazilian Academy of Medicine, Corresponding Member of the National Academy of Medicine of France (2009), and President (since 2012) of the International Federation for Tropical Medicine. He received the Holy Knight (“Palmes Academiques”) by the French Minister of National Education in 2012 and won the Health Sendas Prize in 1997 in Brazil. He is ad-hoc advisor for several Scientific Journals and various government agencies for Research. He has experience in ​​Parasitology and Tropical Medicine, with emphasis on: human Plasmodium falciparum and P. vivax malaria and experimental simian and murine malaria, protective immunity, vaccine trials, malaria immunopathology and malaria Atlantic forest.

peter-digglex300

Professor Peter Diggle  (United Kingdom)

Peter Diggle is Distinguished University Professor of Statistics in the Faculty of Health and Medicine, Lancaster University. He also holds Adjunct positions at Johns Hopkins, Yale and Columbia Universities, and is president of the Royal Statistical Society (2014-2016).

Prof Diggle’s research involves the development of statistical methods for spatial and longitudinal data analysis and their applications in the biomedical, health and environmental sciences. He was awarded the Royal Statistical Society’s Guy Medal in Silver in 1997, and is a former editor of the Society’s Journal, Series B. He was founding co-editor of the journal “Biostatistics” between 1999 and 2009, and is a Biometrika Trustee. He has served the UK Medical Research Council as a member of their Population and Systems Medicine Research Board and now chairs their Skills Development Fellowships Panel.

CD - Copy 

Professor Christian Doerig  (Australia) 

Christian Doerig obtained his PhD in molecular virology at the Swiss Institute for Experimental Cancer Research (ISREC) in Lausanne, Switzerland. After post-doctoral training in virology in the USA, he turned his attention to malaria and he pioneered the study of protein phosphorylation in the human malaria parasite Plasmodium falciparum, and is now a recognised leader in this field.  He is “Directeur de Recherches” at the French biomedical research agency Inserm and Honorary Professor of the University of Glasgow, Scotland.  He established the first Inserm unit in the UK, at the Wellcome Trust Centre for Molecular Parasitology, University of Glasgow, and subsequently in Switzerland at the Inserm-EPFL joint laboratory, Ecole Polytechnique Fédérale de Lausanne (EPFL).  In 2011, he joined Monash University as Head of the Department of Microbiology, a position he held until 2015. He is now a Professor of Microbiology at the same Department, where he pursues his research on the kinomics of malaria parasites.  A recently emerged research topic in his laboratory is the signaling response of host cells to intracellular pathogens, which at the moment covers work in Plasmodium-infected erythrocytes as well as flavivirus-host cell systems.

Rob Don_web 

Dr Robert Don  (Switzerland) 

Rob Don is the Director of research at the Geneva based Drugs for Neglected Diseases initiative (DNDi). In this role he is responsible for developing new chemical entities from screening through lead optimisation and preclinical research to phase 1 clinical trials for a range of neglected diseases including African sleeping sickness, Leishmaniasis, Chagas’ disease and filarial infections. DNDi is 12 years old and Rob has held this role for the last 11 years. During that period, DNDi has developed a strong pipeline of NCEs from preclinical candidates through phase 1, 2 and 3 clinical trials. Prior to joining DNDi he was senior vice president of R&D a Progen Pharmaceuticals in Brisbane. Rob was awarded a first class honours degree and PhD in microbiology at the University of Queensland quite some time ago and focussed most of his career on oncology drug discovery and development before joining DNDi.

 09 副本 (1)

Professor Wang Duoquan  (China) WHO/TDR Sponsored Speaker 

Wang Duoquan, PhD, Professor, at the National Institute of Parasitic Diseases, Chinese Centers for Disease Control and Prevention, Shanghai, China. His main research interests are malaria epidemiology and vector biology, who receives support from TDR and 2014 Asia Pacific Malaria Elimination Network fellowship and the University of California San Francisco. 

 DEngelman_web

Dr Daniel Engelman  (Australia) 

Daniel Engelman is a Paediatrician at the Royal Children’s Hospital, Melbourne, and Research Fellow at the Centre for International Child Health, University of Melbourne and Murdoch Childrens Research Institute. His research interests include echocardiographic screening for the prevention of rheumatic heart disease and community control of scabies and other neglected tropical diseases. He is a Steering Committee member for the International Alliance for the Control of Scabies. 

 DFiddock

Professor David Fidock  (United States of America)  IJP Sponsored Speaker 

David Fidock is a Professor of Microbiology & Immunology and of Medical Sciences (in Medicine) at the Columbia University Medical Center in Manhattan, New York. He received his Bachelor of Mathematical Sciences with Honors from Adelaide University in Australia in 1986 and his Ph.D. in Microbiology from the Pasteur Institute in Paris in 1994. Following postdoctoral research at UC Irvine with Dr. Anthony James and the NIH with Dr. Thomas Wellems, he started his independent group at the Albert Einstein College of Medicine in New York in 2000. He moved to Columbia University in 2007. He is the recipient of awards from the Ellison Medical Foundation and the Burroughs Wellcome Fund and in 2014 was awarded the Bailey K. Ashford Medal from the American Society of Tropical Medicine. His research program focuses on the genetic and molecular basis of antimalarial drug resistance in Plasmodium falciparum, drug discovery, transfection technologies, and parasite lipid and fatty acid metabolism. He has authored over 150 articles in malaria, including the recent application of zinc-finger nuclease-mediated gene editing to study the role of pfcrt, pfmdr1 and K13 in Plasmodium falciparum resistance to first-line antimalarials drugs.

 Didier Fontenille PI (2)

Dr Didier Fontenille   (Cambodia)

Dr Didier Fontenille is a medical entomologist. After 17 years working on malaria and arboviruses vector biology, genetics and control in Africa (Madagascar, Senegal, Cameroon), he has directed the CNRS-IRD-Montpellier University Research Unit MIVEGEC, IRD, Montpellier, France (165 scientists in 11 countries) from  2005 to 2014. During his period in France he has initiated research work on potential arboviruses and malaria vectors in Europe.

He was the first director of the CNEV (French national reference center on Vectors), France, from its beginning in 2011 to 2014. He has been the initiator and Coordinator (13) or co-PI of 32 scientific projects and training networks, mainly in Africa and Europe between 1990 and 2015 (ANR, EU, WHO, NIH, etc.).

He has been Member of several European Networks (VBornet, BioMalPar / Evimalar, Infravec, EDEN, ESOVE), and experts in medical entomology for several international bodies (WHO, ECDC, EU). Since November 2014, he is the director of the Pasteur Institute in Cambodia (IPC), leading a staff of 220 people. IPC is conducting research and expertise works on infectious diseases, including major mosquito borne diseases like malaria, dengue, Japanese encephalitis and Chikungunya. He continues to supervise students in Europe and in Cambodia on mosquito biology and systematics. He has more than 310 publication of book chapters, mainly in the field of mosquitoes and mosquito borne diseases

 Freya Headshot(200x300)

Dr Freya Fowkes  (Australia) 

Dr Freya Fowkes is an ARC Future Fellow and Head of Malaria and Infectious Disease Epidemiology at the Burnet Institute, Melbourne, Australia. She trained in the key disciplines of parasitology (BSc(Hons) Parasitology, University of Glasgow), epidemiology and statistics (MSc Epidemiology, LSHTM; DPhil Infectious Disease Epidemiology, University of Oxford), including post-doctoral positions in malaria epidemiology at New York University and the Walter and Eliza Hall Institute. Freya currently leads a large multidisciplinary research team based in Melbourne, Myanmar and Papua New Guinea. The primary focus of her work is the epidemiology of malaria, drug resistance, immunology, and malaria elimination. By studying these key processes and their interactions using laboratory assays, population studies, clinical trials and innovative analytical approaches, her studies have led to significant translational advances in the field of malaria epidemiology, control and elimination. 

 JFrancis_web

Dr Josh Francis  (Australia) 

Dr Joshua Francis is a Paediatric Infectious Diseases Specialist, working at the Royal Darwin Hospital in the Northern Territory. He is a Lecturer with the Flinders University Northern Territory Medical Program, an Adjunct Senior Lecturer with James Cook University, and an Honorary Clinical Fellow with the Menzies School of Health Research, Charles Darwin University. Josh is passionate about global and Indigenous child health, and in addition to his clinical and academic roles in the Northern Territory, he also provides leadership to projects in Timor-Leste that are focussed on strengthening healthcare delivery, clinical training and operational research. 

 ngeard_small

Dr Nicholas Geard  (Australia)

Nic Geard is a Research Fellow with the Modelling and Simulation Unit, Centre for Epidemiology, Melbourne School of Population and Global Health, where he develops computational models of infectious diseases to help address questions about their transmission and control in diverse populations. He is a CI on the NHMRC funded Centre for Research Excellence in Policy-Relevant Infectious Diseases Simulation and Mathematical Modelling. 

 NGolding_web

Dr Nick Golding  (Australia) 

Nick Golding is a McKenzie Fellow at the University of Melbourne, where he’s developing new improving models and software to improve mapping of species as well as infectious diseases and their impacts.

Michael Good (280 x 320)

Professor Michael Good  (Australia)

Michael Good is a NHMRC Senior Principal Research Fellow at Griffith University, the past Director of the Queensland Institute of Medical Research (QIMR) and a former Chairman of the National Health and Medical Research Council. 

Professor Good graduated MD PhD DSc from the University of Queensland and the Walter and Eliza Hall Institute of Medical Research. He undertook postdoctoral training at the US National Institutes of Health in Bethesda, Maryland.  His interests are in immunity and vaccine development for malaria and streptococcus. His group has developed candidate vaccines, which are now in clinical trials. He is an author of over 300 publications and is an inventor on 20 patents.

In 2006 he was awarded Honorary Membership of the American Society of Tropical Medicine and Hygiene. In 2007 he won the Ross Hohnen Prize for Research Excellence from the National Heart Foundation. In 2009 he won the Australia Museum CSIRO Eureka Prize for Leadership in Science.  In 2010 he was awarded an Australia Fellowship. He is a Fellow of the Australian Academy of Technological Sciences and Engineering and the Australian Academy of Health and Medical Sciences. Professor Good is an Officer of the Order of Australia. 

 S-Graves

Professor Stephen R. Graves  (Australia)  

Professor Stephen R. Graves is the Founder and Medical Director of the Australian Rickettsial Reference Laboratory based at Geelong Hospital in Victoria, Australia. This small, not-for-profit diagnostic and research laboratory undertakes laboratory diagnoses of Q Fever and other tick-transmitted infections. He was formerly Senior Lecturer in Microbiology at Monash University, and the Director of Microbiology at the public hospitals in Townsville [QLD] , Geelong [VIC]  and Newcastle [NSW]. He is a member of the Commonwealth Government National Pathology Accreditation & Advisory Committee [NPAAC], which overseas human pathology diagnostic services in Australia. He is a Fellow of the Royal College of Pathologists of Australasia, the Australian Society for Microbiology and the Australian College of Tropical Medicine. He has published widely in the fields of Q Fever, rickettsiae and spirochaetes.

 IGremiao

Dr Isabella Dib Ferreira Gremião  (Brazil)

Isabella Gremião is Researcher of the Laboratory of Clinical Research on Dermatozoonosis in Domestic Animals, a center for the diagnosis and treatment of fungal diseases in animals, which belongs to the Evandro Chagas National Institute of Infectology, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil. FIOCRUZ is a public institution of the Brazilian Ministry of Health, which is considered the most prominent science and technology health institution in Latin America.

Isabella Gremião received her Veterinary Medicine degree from the Fluminense Federal University (Rio de Janeiro, Brazil) in 1998 and her masters degree in Veterinary Medicine and Surgery from the same University in 2002. She was awarded a PhD in Clinical Research in Infectious Diseases in 2010 at the Oswaldo Cruz Foundation. She is also a member of the Ethics Commission on Animal Use of Oswaldo Cruz Foundation and the Research Ethics Committee of Evandro Chagas National Institute of Infectology.

Isabella Gremião has authored and co-authored over 30 referenced publications since 1997 in the field of surgery, anesthesiology and infectious diseases in domestic animals. In the last years her key research interests include the epidemiological, clinical and therapeutic aspects of sporotrichosis in animals as well as the diagnosis and zoonotic transmission of this disease.

CHall_ph 

Dr Charlotte Hall  (United Kingdom) 

Charlotte Hall is a British Infectious Diseases trainee who qualified in 2006. Her love of medicine in the tropics has taken her to practise in many destinations including Vanuatu, the Thai-Burma border, Cambodia, Kenya, South Africa and, most recently, Timor-Leste. Particular interests include TB, HIV, viral hepatitis and health systems strengthening in LMIC.

She holds distinctions in the DTM&H and her MPH, which focused on the challenges of delivering isoniazid preventive therapy (IPT) for TB to children in Timor-Leste. Recent publications include a study of the prevalence of hepatitis B in pregnant women in Timor-Leste and an analysis of the uptake of IPT among a cohort of children exposed to TB. While in Timor-Leste she helped design and deliver a training programme for a healthcare-worker-delivered community-based model of contact tracing and IPT. This work led to her being a finalist in the recent RCP Excellence in Patient Care awards. Ongoing research includes a 5-year prospective study of TB epidemiology in Timor-Leste.

Charlotte would ultimately like to undertake a mixture of clinical work, capacity building activities, and operational research focused on understanding the health needs in LMIC and developing health systems to meet these. She has recently been awarded a Tropical Health and Education Trust grant to create a health partnership between her UK place of work and Bairo Pite Clinic in Timor-Leste.

RHall-web

Professor Roy Hall  (Australia) 

Roy Hall is Professor of Virology in the Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences at the University of Queensland. Roy’s research focuses on the discovery and characterisation of new and emerging arthropod-borne viruses and characterisation of their phylogenetics and taxonomy, pathogenesis in vertebrates and their effect on the vector capacity of their mosquito host. These studies have led to the discovery of many new mosquito-borne viruses in several viral families and spawned the development of novel reagents and strategies for virus discovery, identification and diagnosis. They have also inspired major projects to identify and characterise novel viral agents that naturally regulate arboviral transmission.

 KHalton_web

Dr Kate Halton  (Australia) 

Kate Halton is a Lecturer in Health Economics at Queensland University of Technology. She holds a PhD in health economics and infectious disease epidemiology. The focus of her research is on producing robust estimates of the economic burden of infectious disease, and identifying cost-effective ways of preventing or treating infection in tertiary, primary and community models of healthcare. She has a particular interest in soil transmitted helminths, healthcare associated infection, and antimicrobial resistance. Kate’s work is distinguished by strong partnerships with health professionals and other end-users, an international focus, and a commitment to translation and dissemination of findings.

Currently, Kate and her team are conducting economic evaluations of a number of novel disease control initiatives under trial, to understand whether they offer value for money. These include the Magic Glasses project in China and the Philippines (a health promotion intervention based around a cartoon DVD aimed at reducing parasitic worm infections) and the GAPS study in Australia (a multimodal intervention to reduce antimicrobial prescribing in general practice). Kate is also undertaking an evaluation of the efficiency of the Philippines Integrated Helminth Control Program to provide evidence for program planning.

 THannan_web

Dr Terry Hannan  (Australia) 

Dr Hannan is a full time practicing Specialist Physician in General Internal Medicine at the Launceston General Hospital where he is also an Associate Professor to the Menzies Research Institute in Hobart. His roles in e-Health and health reform began with the first successful international translocation of a complex clinical information system from the Johns Hopkins Oncology Centre into the Prince of Wales/Prince Henrys Hospitals in Sydney. (1984-1992). He is an inaugural Fellow of the Australasian College of Health Informatics (ACHI) and a former College President.

In 2004 he was elected an International Fellow of the American College of Health Informatics (ACMI). In 2000 he was invited to be a co-founder of the Mosoriot Medical Record System (MMRS) an Electronic Medical Record (EMR) project in Kenya. This remains a collaborative project between the Moi University in Eldoret Kenya and the Regenstrief Institute in Indiana. The MMRS project led to the development of the Academic Model for the Provision and Access To Healthcare (AMPATH) and the OpenMRS e-record systems (www.openmrs.org ). Currently OpenMRS is the largest open-source web based EMR for developing nations. His main focus has been on end-user acceptability of eHealth technologies. He is currently a Moderator for two international web-based resource projects GHDonline (www.ghdonline.org ) whose aim is to improve health care delivery through global collaboration and the mHealth Working Group (https://www.mhealthworkinggroup.org/). 

 J-Haselden-web

Dr John Haselden  (Spain) MMV Special Symposium Speaker

Since 2014 John has been the VP and Head of the Malaria Discovery Performance Unit (DPU) for GSK R&D, based in Spain. This unit is at the forefront of pharmaceutical engagement in the field of malaria, and is part of the Disease of the Developing World Research facility based near Madrid. Across these neglected diseases, GSK leads the way in its innovative approach to sharing of data, access to compound libraries and its openness around IP issues.

John joined Wellcome as a toxicologist in the early 90s after completing his PhD in lipid biochemistry at London (now Imperial). In 2000 he became the Director of Investigative Toxicology and as a project manager, accumulated extensive drug development expertise across a number of therapeutic areas (biopharm, GI, neurosciences, respiratory, infectious diseases).

Until 2008 John was responsible for the evaluation of metabolomic platforms within GSK and built an extensive network with the KOLs in this field. Furthermore he has served on numerous editorial and advisory boards – many in relation to Euro-centric projects on metabolomics and biomarker research, has held various visiting lecturer positions in the UK, and is currently a Visiting Professor in Biomolecular Medicine at Imperial College. 

 GHC

Dr Grant Hill-Cawthorne  (Australia)

Dr Grant Hill-Cawthorne is a medical microbiologist and the Senior Lecturer in Communicable Disease Epidemiology at the Marie Bashir Institute and School of Public Health, University of Sydney. After completing medicine and medical training at the University of Cambridge he went to Saudi Arabia where he set up a laboratory specialising in pathogen genomics. His PhD was in the use of genomics for public health microbiology and as part of this he led a large worldwide study on TB genomics as well as studies on total drug resistant TB in South Africa. His ongoing research is on the use of molecular epidemiology for public health policy, particularly focusing on emerging infections, drug resistance and the impact of mass gatherings. Grant is the unit coordinator for the communicable disease units within the Master of International Public Health and Master of Public Health. He has also co-developed a new degree: the Master of Health Security.

 

Dr Stephen Hoffman  (USA)

Dr. Hoffman is Chief Executive and Scientific Officer of Sanaria Inc., a company dedicated to developing a whole sporozoite malaria vaccine, a vaccine which won the 2014 Vaccine Industry Excellence (VIE) Award for “Best Prophylactic Vaccine,” and Chairman of Protein Potential LLC, a company focused on subunit vaccine development. From 1987-2001 he was Director, Malaria Program, Naval Medical Research Center where he and his team were leaders in subunit malaria vaccine development and sequencing the Plasmodium falciparum genome and conducted the first studies showing DNA vaccines elicited killer T cells in humans. In 2001 he joined Celera Genomics as Senior VP, Biologics and created a program to utilize genomics/proteomics to produce biopharmaceuticals and personalized medicines, and organized sequencing of the Anopheles gambiae genome. He has held several professorships, is past president of ASTMH, and authored > 400 scientific publications. He is the most highly cited author in the world for scientific papers on malaria published between 1995 and 2005, was listed as the third most influential person in the world vaccine industry in 2015. He was elected to membership in the National Academy of Medicine in 2004. In 2016 he received the Distinguished Alumni Award from Weill Cornell Medical College.

 Jenkins, David 2007

Dr David Jenkins  (Australia)

David Jenkins was born in the UK and attended the University of London where he undertook an undergraduate degree in botany and zoology, followed by a post graduate degree in immunology. He then spent two years in Indonesia working on hookworms in humans. From Indonesia he went to the vet school at the University of Melbourne where he did his PhD studying the immune response of dogs to infection with tapeworms. After finishing his PhD he became a researcher on a hydatid control project in north-western Kenya, together with Thomas Romig who is also presenting at this meeting. Jenkins  returned to Australia as research officer on a hydatid control program based in Canberra. He investigated the role of wildlife in the transmission of hydatid disease in south-eastern Australia and also undertook testing new de-wormers for dogs and cats against hydatid tapeworms. He moved to Charles Sturt University in 2008 where he is a Senior Research Fellow in the School of Animal and Veterinary Sciences teaching parasitology, supervising post graduate students and undertaking research on tapeworm transmission and control.

 Kain Kevin_small

Dr Kevin Kain   (Canada) 

Dr. Kain is the Director, SAR Laboratories, Sandra Rotman Centre; Director, Tropical Disease Unit at UHN-Toronto General Hospital; and holds a Canada Research Chair. Dr. Kain is the recipient of the C. Woolf Award for the Excellence in Teaching from the University of Toronto, a Career Scientist Award from the Ontario Ministry of Health, the Young Investigators Award from the Canadian Infectious Disease Society, the Bailey Ashford Medal from the American Society for Tropical Medicine and Hygiene, awarded for “Distinguished work in tropical medicine”, and the SL Medal (from Mahidol University, Thailand) for “Outstanding achievements in malaria research”. Dr Kain was profiled by TIME magazine as one of “Canada’s Best in Medicine”. He has received the: Pfizer Visiting Professorship, University of Washington; Fred Barrett Lectureship, University of Tennessee; Distinguished Global Health Service Award, University of California; The Henry Wong Lectureship In Medicine, MacMaster University; Forbes Lectureship, University of Melbourne. He has served as a consultant to the Gates Foundation, WHO, Red Cross, PATH and the CDC. Dr. Kain’s research efforts are focused on translational research for major global infectious disease threats particularly as they pertain to pregnant women and children. Dr Kain’s efforts also focus on global equity and knowledge sharing, including the training of investigators in low resource settings, enabling and empowering them to address their own problems in a sustainable fashion.

Peer-reviewed Research Support: totals over $75,000,000
Peer reviewed Publications: over 280

 MKama_web

Dr Mike Kama  (Fiji) 

Currently works as the Principal Medical Officer at the Fiji Ministry of Health’s Centre for Communicable Disease Control. After completing the first 4 years of work with clinical medicine in rural health facilities and emergency medicine at the country’s reference hospital, he joined the Fiji Ministry of Health’s HIV prevention program initiative in 2005 and, together with a network of inspired Doctors, coordinated the Fiji Ministry of Health’s operational efforts to provide accessible services to HIV affected individuals using the WHO Comprehensive Continuum of Care Service prototype. Following that successful initiative, he joined the Ministry’s Centre for Communicable Disease Control in 2007, and dedicates himself in working with a network of infectious diseases specialists from within the country and abroad, in spearheading the country’s communicable disease prevention and control efforts. His key areas of focus and interest in infectious disease medicine revolves around the three groups of prioritized infectious diseases for Fiji and other Pacific islands, namely Arbovirus diseases, Leptospirosis and Typhoid Fever.

 TKearnes

Professor Thérèse Kearns  (Australia)  

TK is a public health researcher who joined Menzies in 2006 and has worked on multiple different quantitative and qualitative projects covering maternal and child health, skin health (scabies, impetigo, tinea), rheumatic heart disease, parasitic infections and anaemia. TK is passionate about closing the gap in health disparaties between Australian Indigneous and non-Indigenous people by providing evidence from locally based research that can be used to change and improve public health policy and practice.

TK’s career highlights include the development and implementation of a VET package, ‘Certificate II in Community Health Research’ that provides nationally acreddited training for local Indigneous community members to be employed on research projects conducted in their communities.

TK lectures in the Master of Public Health, provides tutoring for the Koori Institute and Flinders University and currently supervises two PhD students and five master students. She has also been awarded over $2.5M in competitive funding grants.

 NKetheesan-web

Professor Natkunam Ketheesan  (Australia) 

Natkunam Ketheesan is an academic at James Cook University in Queensland, Australia and is a lead researcher within the Australian Institute of Tropical Health and Medicine. After obtaining an MD, he went on to complete a Masters in Clinical Immunology followed by a PhD in Immunology at the University of Leeds. He worked as a Research Fellow in the Universities of Leeds, Western Australia and Queensland before joining JCU. At JCU he currently holds a Personal Chair in Infection and Immunity. Ketheesan’s research efforts focus on investigating the interactions that occur between selected tropical bacterial pathogens and the human host, to enable the development of strategies to better identify and combat infections and their complications. His group has been involved in determining host-pathogen interactions in rheumatic heart disease (RHD), melioidosis and Q fever. One of their major achievements has been the immunological and functional characterisation of the rat autoimmune valvulitie model, the only credible model of RHD that is relevant to this uniquely human autoimmune disease. Ketheesan’s research has been supported by both international and national funding agencies.

 NKarunaweera

Dr Nadira Karunaweera  (Sri Lanka) 

Nadira is the Head of Department, Senior Professor and Chair of Parasitology, Faculty of Medicine, University of Colombo, Sri Lanka and Visiting Scientist, School of Public Health, Harvard University, USA. She is a Medical Parasitologist by training and has over 25 years of teaching and research experience in medical parasitology, with a special emphasis on vector-borne tropical diseases. She is a Fellow of the National Academy of Sciences of Sri Lanka (NASSL) and was recently elected as the General Secretary of NASSL (2015-2017). She has been a recipient of several competitive research grant awards that amount to over a million US dollars. Awards for her scientific accomplishments include Presidential Award for excellence in research, National Apex Award for Professional Excellence and Zonta woman of the year award. She is considered as an authority in malaria research that encompasses wide ranging fields including pathogenesis, epidemiology, immunity and genetic diversity; has been instrumental in generating novel information, which have aided the process of policy making related to control and elimination of this disease from Sri Lanka. She continues to function as a team leader in multidisciplinary research studies in human parasitic infections and is responsible for pioneering work in the field of leishmaniasis, as newly established disease in Sri Lanka, with setting up of the first diagnostic and research laboratory in the country with in vitro culture facilities and molecular techniques. She has provided academic supervision and guidance to a large number of undergraduate and post-graduate students and has been in the University system for over 25 years (University of Colombo, Sri Lanka; University of Edinburgh, UK; Harvard University, USA) with extensive academic and administrative experiences. As an expert in tropical diseases she continues to serve on many national and international scientific and consultative committees or boards providing her expertise in an honorary capacity. She has organized national and international conferences, workshops and capacity building programs and has led the team that established the first-ever ‘Research Promotion and Facilitation Centre’ in the Faculty in 2013 that continues to provide training and promotes capacity building of young local researchers. She has published widely with a Google Scholar h-index of 23; i-10 index of 42 and has authored over 70 peer-reviewed journal articles, over 100 abstracts of presentations made at conferences, book chapters and shares the ownership of 2 patents. 

 Dr. HSSKhin

Dr Hnin Su Su Khin  (Myanmar) 

Dr Hnin Su Su Khin (Ma Su), as the program director, takes a leading role in the strategic, technical and programmatic direction of the PSI Myanmar malaria program. She manages PSI’s malaria program to deliver malaria control, diagnosis and treatment services through the private sector at a national scale. Ma Su started with PSI in 2009 as a Research Manager. Prior to joining PSI, she worked as a medical doctor and team leader for Médecins Sans Frontières. She also has 7 years’ experience in the private sector, working for Nestle and United Pharma Co. Ltd as the medical specialist and sales and marketing management roles. Ma Su received her MBBS from the University of Medicine in Mandalay and her Master of Public Health from BRAC University in Dhaka.

K.Kirk

Professor Kiaran Kirk  (Australia)

Kiaran Kirk is Dean of the Australian National University’s College of Medicine, Biology and Environment.  His research is on the physiology, biochemistry and pharmacology of the malaria parasite.  Professor Kirk carried out his PhD in the Department of Biochemistry at the University of Sydney (1985-1988). In 1989 he went to the Oxford University Laboratory of Physiology where he held an Oxford Nuffield Medical Fellowship, the Staines Medical Research Fellowship (Exeter College) and a Lister Institute Senior Research Fellowship. He returned to Australia in 1996 to head the Department of Biochemistry and Molecular Biology in the ANU Faculty of Science, holding this post until taking up the role of Director of the newly-created ANU Research School of Biology in June 2009.  Professor Kirk took up his current role as Dean of the ANU College of Medicine, Biology and Environment in April 2014.

Professor Kirk’s research focuses on the cell physiology of the malaria parasite, with a particular interest in membrane transport proteins, their potential as antimalarial drug targets, and their role in antimalarial drug resistance.  He has published over 140 papers, primarily on this topic (see http://www.researcherid.com/rid/C-8299-2009 for details).

Albert CPqGM foto

Dr Albert Ko  (United States of America)

Dr. Albert Icksang Ko, an infectious disease physician, is a Professor and Chair of the Department of Epidemiology of Microbial Diseases at Yale School of Public Health and Collaborating Researcher at the Oswaldo Cruz Foundation, Brazilian Ministry of Health.  His research focuses on the health problems which have emerged as a consequence of rapid urbanization and social inequity.  Dr. Ko coordinates a research and training program on urban slum health in Brazil, where his group is conducting long-term prospective studies on urban health problems which include dengue, meningitis and respiratory infections and more recently Zika virus infection and congenital syndrome.  His work is particularly interested in understanding the natural history of leptospirosis, which is as a model for an infectious disease which has emerged in slum settlements due to the interaction of climate, urban ecology and social marginalization.  On-going research combines multidisciplinary epidemiology, ecology and translational research-based approaches to identify prevention and control strategies which can be implemented in slum communities. Dr. Ko is the Program Director at Yale for the Fogarty Global Health Equity Scholars Program which provides research training opportunities for US and LMIC post and pre-doctoral fellows at collaborating international sites.

 vicki-krause

Dr Vickie Krause  (Australia)

Vicki Krause, MD, DTM&H and FAFPHM is the Director of the Northern Territory (NT) Centre for Disease and Head of the TB/Leprosy Unit, NT Department of Health. She is a member of the Communicable Diseases Network Australia (CDNA), the National Tuberculosis Advisory Committee and inaugural (2001) and continuing Chair of the National Pneumococcal Disease Working Group for CDNA. She participated in WHO TB missions to Indonesia for many years, previously worked in PNG as a specialist physician and serves on the WHO TB Technical Advisory Group for the Western Pacific Region.

 

 Dennis-Kyle_square _web

Professor Dennis Kyle  (United States of America)

Dennis E. Kyle, PhD, is a Distinguished University Health Professor in the Department of Global Health at the University of South Florida in Tampa. He majored in Biology at the University of Tennessee at Chattanooga (BA, 1979) and completed a PhD in Zoology at Clemson University (1984). Following a postdoctoral position at the University of Georgia, he worked at the Walter Reed Army Institute of Research (WRAIR) for over 20 years. During this time he led key efforts with the US Army’s Drug and Vaccine Development Programs, eventually serving as Deputy Director of the Division of Experimental Therapeutics at WRAIR. He also served  at the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand (1991-94) and was a senior scientist at the Australian Army Malaria Institute (AMI) from 2002-04. 

His research interests include elucidation of mechanisms of antimalarial drug resistance and discovery of new anti-parasitic drugs for diverse disease including malaria, visceral leishmaniasis, and primary amoebic meningoencephalitis. Dr. Kyle has more than 175 publications in the peer-reviewed scientific literature and is a Fellow of the American Society for Tropical Medicine and Hygiene and the American Association for the Advancement of Science. His lab is supported by research funding from National Institutes of Health, the Bill and Melinda Gates Foundation, and Medicines for Malaria Venture.

CLau

Dr Colleen Lau  (Australia) 

Colleen’s research interests include infectious disease epidemiology, environmental health, spatial epidemiology, travel medicine, tropical medicine, and the impact of global environmental change on infectious diseases. She collaborates with WHO and Ministries of Health in the Pacific Islands on research projects to inform public health strategies and interventions, and her current field projects include epidemiological studies of leptospirosis in Fiji, and lymphatic filariasis elimination in American Samoa. Colleen also works as a travel medicine doctor and general practitioner, and leads clinical research projects on travel vaccines, malaria prophylaxis, and illness in travelers.

 Peter Leggat_web

Professor Peter Leggat  (Australia)

Professor Peter A. Leggat, AM, MD, PhD, DrPH, FAFPHM, FFPH RCP(UK), FACAsM, FFTM RCPSG, FFEWM ACTM, FISTM, HonFFPM RCP(UK), HonFACTM, HonFFTM ACTM, is Director, World Safety Organization Collaborating Centre for Travel Health and Safety, College of Public Health, Medical and Veterinary Sciences, James Cook University (JCU), Australia. He joined JCU in 1992 and heads up one of the largest postgraduate public health and tropical medicine programs in Australasia, including the Postgraduate Travel Medicine Course, which commenced in 1993. He has consulted for a number of national and international organisations, including the Department of Defence, the Therapeutic Goods Authority and the World Health Organization. He has also been a Visiting Medical Officer for Defence in Townsville since 1992 and holds honorary professorships in six universities in three countries. Professor Leggat is a Founder Member of the ISTM and currently serves as ISTM Secretary-Treasurer. He has also served as President of The Australasian College of Tropical Medicine from 1996-98, 2002-04, 2006-08, and commences a fourth term in 2016. He has served on the Editorial Boards of both the Journal of Travel Medicine and Travel Medicine and Infectious Disease. A former Fulbright Scholar, he has published >500 journal papers, >20 books, and >80 chapters.

 photo of Lydia R. Leonardo

Dr Lydia Leonardo  (Phillippines) WHO/TDR Sponsored Speaker

Dr. Lydia R. Leonardo is a professor in Parasitology at the College of Public Health of the University of the Philippines Manila. She finished her Doctor of Public Health degree major in Parasitology at the same college and took her postdoctoral course at Tulane University in New Orleans, Louisiana, USA. Her field of expertise is in schistosomiasis, soil-transmitted helminthiases, food-borne trematodiases and medical malacology. Her publications include various topics in biochemistry, epidemiology, diagnosis and prevention and control of schistosomiasis. She has presented papers in several national and international conferences about her researches on various aspects of schistosomiasis. Her research collaborations include partnerships with Dokkyo Medical University, Nagasaki University and Obihiro University of Agriculture and Veterinary Medicine in Japan and University of Queensland in Australia. She has been the secretary of the Regional Network on Asian Schistosomiasis and other Helminthic Zoonoses since 2000. She is also the incumbent vice-president of the Philippine Society of Parasitology. Her latest assignments are membership in the Technical Working Group for Neglected Tropical Diseases (NTDs) of the Philippine Department of Health and membership in the Strategic and Technical Advisory Group for NTDs of the World Health Organization.

 MLittrell

Dr Megan Littrell  (United States of America) 

Dr. Megan Littrell is the Principal Investigator for the ACTwatch project at PSI. She leads the ACTwatch malaria medicines and diagnostics market research portfolio in 13 countries across sub-Saharan Africa and the Greater Mekong Sub-Region. She has previously served in malaria research advisory roles at PSI and PATH and holds a PhD from the Tulane University School of Public Health and Tropical Medicine. ACTwatch is a multi-country research project implemented by PSI since 2008. Standard tools and approaches are employed to provide comparable data across countries and over time. ACTwatch is designed to provide timely, relevant and high quality antimalarial market evidence. The goal of providing this market evidence is to inform and monitor national and global policy, strategy, and funding decisions for improving malaria case management. ACTwatch is monitoring antimalarial markets in the context of policy shifts and investments in the scale-up of first-line ACT and blood testing using RDTs. This has included adaptation of project methods for the evaluation of the Affordable Medicines Facility-malaria (AMFm) pilot. Project scale-up in the Greater Mekong sub-Region in 2015 was designed to deliver key indicators for informing and monitoring strategies and policies for malaria elimination. See www.actwatch.info for more information. 

 IanMackay_web

Associate Professor Ian Mackay  (Australia) 

Associate Professor Ian Mackay is a virologist who was awarded his Ph.D. in 2003 from The University of Queensland. He spent 23 years at the Sir Albert Sakzewski Virus Research Centre, Queensland Health and The University of Queensland, producing more than 80 papers, chapters and reviews about his research into human respiratory viruses. In 2015 Ian left bench research and moved to a Supervising Scientist role at Forensic and Scientific Services, Queensland Health, supporting the detection and characterization of known, new, newly identified, rare and emerging viral threats to public health.

Apart from manuscript and grant reviewing roles, Ian is an Associate Editor at the Journal of Clinical Virology and an Editor at Viruses. His interests include virus hunting, respiratory viruses (particularly coronaviruses, influenza viruses and the picornaviruses), virus:virus interactions, virus detection and discovery, emerging viruses, writing and leveraging social media to inform, engage and educate about aspects of virology.

 

Professor Suresh Mahalingam  (Australia)

Professor Suresh Mahalingam has an international reputation in the field of viral pathogenesis and has spent the last 19 years investigating the interactions between viruses and their hosts. He is an internationally recognized leader in arbovirus research. Over the last decade he has evolved into a leader in viral-induced inflammatory disease, an international reputation arising from his alphavirus and respiratory virus research. The work has led to several fundamental discoveries on key processes in viral immunopathogenesis, which have implications in other infectious diseases, published in leading specialist and generalist journals. His contribution to fundamental research is complemented by clinical and translational ‘spin-offs’ supported by a number of highly productive collaborations with clinician-scientists, commercial partners and government agencies. As a result of high-level research success, he has received numerous awards and fellowships. He obtained his PhD from the John Curtin School of Medical Research at the Australian National University. He is currently Principal Research Leader and NHMRC Senior Research Fellow at the Institute for Glycomics, Griffith University. He is also the deputy director of the Queensland Tropical Heath Alliance.

 Ben Marais_Nr 1

Professor Ben Marais  (Australia)   

Professor Ben Marais works in Paediatric Infectious Diseases at the Children’s Hospital at Westmead.  He is Deputy-Director of the Marie Bashir Institute for Infectious Diseases and Biosecurity (www.sydney.edu.au/mbi) and helps to lead the Centre for Research Excellence in Tuberculosis (www.tbcre.org.au) at the University of Sydney.  His research has focussed primarily on how children are affected by the global tuberculosis epidemic and the spread of drug resistant M. tuberculosis strains. 

 medley

Professor Graham Medley  (United Kingdom) 

Graham Medley is Professor of Infectious Disease Modelling at the London School of Hygiene and Tropical Medicine. He has current projects on leprosy and visceral Leishmaniasis (through the NTD Modelling Consortium), and is also working on modelling the social processes involved in HIV transmission. Graham’s first degree was in Biology and Computer Science (University of York, 1982), and although computer science has moved on (paper tape is quite rare these days), this combination gave him an early insight into modelling biological populations. He has been working on infectious disease transmission dynamics since his PhD at Imperial College, London.

Graham has worked on many different pathogens (viruses, bacterial, protozoa, helminths) in many different hosts and vectors, and has about 170 peer-reviewed publications. He is particularly interested in understanding how interventions are and should be designed to control infectious disease – the definition of “interventions” includes both the biological (e.g. immune response) and societal action (e.g. immunisation). Mathematical models are tools for understanding, just as much tools for prediction. Graham is currently an editor of Epidemics, a handling editor for Mathematical Biosciences and on the board of reviewing editors for Science.

 WMeyer

Professor Wieland Meyer  (Australia)

Professor Wieland Meyer is the Head of the Molecular Mycology Research Laboratory at the Center for Infectious Diseases and Microbiology, Professor for Molecular Medical Mycology, Sydney Medical School – Westmead Hospital, Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Westmead Institute for Medical Research, Sydney, Australia, and Guest Professor at Fondação Oswaldo Cruz (FIOCRUZ) in Rio de Janeiro, Brazil. PhD in 1992 with Thomas Börner at the Humboldt University, Berlin, Germany – established DNA and PCR fingerprinting for fungal strain typing. Postdoc from 1992 -1995 with Thomas Mitchell at Duke University Medical Center, Durham, NC, USA – phylogeny of human pathogenic yeasts and epidemiology of cryptococcosis. Establish the Molecular Mycology Research Laboratory at Westmead Hospital, Sydney in 1995. His research focuses on evolution, speciation, population genetics, genomics, molecular epidemiology and typing, of human pathogenic fungi (e.g. Candida, Cryptococcus, Scedosporium and Pneumocystis), the development of molecular identification techniques for human/animal fungal pathogens, and the understanding of fungal pathogenesis on a molecular level. He investigates the global epidemiology of Cryptococcus neoformans/C. gattii, established a multilocus sequencing typing scheme (mlst.mycologylab.org) and does whole genome population analysis of C. gattii. He lead the establishment of the ITS database (its.mycologylab.org) and identified alternative loci for fungal DNA barcoding. His is funded by: the NH&MRC Australia, the NIH, USA and CAPES, Brazil. He is curator of the Westmead Medical Mycology Culture Collection, housing over 16000 strains. He has published more than 170 research papers. He was the Vice-President and is currently General Secretary of the International Society of Human and Animal Mycology (ISHAM). He was the Vice-President of International Mycological Association (IMA) from 2006-2010. He is currently a member of the executive committee of the IMA. He was also the Vice-President (1998-2002) and the President (2002-2005) of the Australasian Mycological Society.

Adrian-Profile-Picture

Professor Adrian Miller   (Australia)

Adrian is of the Jirrbal people of North Queensland and is the Professor of Indigenous Research at Griffith University leading the Indigenous Research Unit and Network. His previous appointments include Professor and Head of School at Southern Cross University’s College of Indigenous Australian Peoples, Senior Lecturer at James Cook University, Founding Head of the Department of Indigenous Studies at Macquarie University and Deputy Head of School at James Cook University’s School of Indigenous Australian Studies. During the past 20 years in higher education, his experience has been in management, leadership, academic program development, teaching and research. He has held Professorial adjunct appointments at 3 Australian universities and has made significant contributions to Indigenous health and education. Professor Miller has a research track record in competitive grants with both the Australian Research Council (ARC) and National Health and Medical Research Council (NHMRC) grant schemes. He has a strong interest in applied and translational research and twice been awarded Australian College of Educators Teaching Award. He has undertaken leadership roles in community-based and government committee’s to advocate the views of Aboriginal and Torres Strait Islander families. His most notable experience is being an invited speaker at the Oxford Round Table, Rhodes House in Oxford University. The highly collaborative manner in which he has undertaken research has contributed to intellectual and methodological developments in health and education fields. His strong interest in barrier to controlling infectious diseases in Indigenous communities is leading to vaccine development and raising the profile of neglected tropical diseases.

 

Dr Marshall Morningstar  (United States) MMV Special Symposium Speaker

Marshall Morningstar, PhD is the Director of Medicinal Chemistry at the Broad Institute Center for the Science of Therapeutics. Marshall obtained a BS in chemistry at University of California, Berkeley, and a PhD in synthetic organic chemistry at Massachusetts Institute of Technology (1994). Following a postdoctoral position at the National Cancer Institute and a short period as a medicinal chemist at Tanabe Research Laboratories, he joined AstraZeneca as a project leader working in Infection research at the Waltham location for 11 years. In 2012, he took on the role as Head of Chemistry for Collaborative Discovery efforts for metabolic, pain and oncology research for GVK BIO working out of Hyderabad, India. Starting 2015, he joined the Broad Institute where he oversees a portfolio of neglected disease programs.

JMorris 

Dr Jodie Morris  (Australia) 

Dr Jodie Morris is a Research Fellow within the Australian Institute of Tropical Health and Medicine (AITHM), James Cook University (JCU). Dr Morris’ primary research interest is the immunopathogenesis of infectious diseases. She has worked with Burkholderia pseudomallei, the causative agent of melioidosis for over a decade, investigating cellular immune responses involved in protection against the disease. Over the past 5 years, Dr Morris has been instrumental in developing and characterising an animal model of type 2 diabetes (T2D). This model is facilitating identification of key mechanisms underlying the increased susceptibility of individuals with pre-existing T2D, toward bacterial pathogens such as B. pseudomallei and Mycobacterium tuberculosis.

KMounsey_web 

Dr Kate Mounsey  (Australia)  

Dr Kate Mounsey completed her PhD in 2007 at the Menzies School of Health Research, investigating the molecular basis of emerging ivermectin resistance in scabies. From 2008-12 she received an NHMRC Training Fellowship for Aboriginal and Torres Strait Islander Health Research, undertaken through the QIMR Berghofer Medical Research Institute. Here she continued her research on drug resistance, and was a lead contributor to the establishment of a porcine model of scabies, facilitating the development of new research directions for scabies. In 2012 she moved to USC, and was awarded an ARC DECRA fellowship, with research focused on profiling the development of immune responses in different clinical manifestations of scabies in the porcine model and clinical patients. Other areas of research include developing field-friendly diagnostics for scabies and strongyloidiasis, exploration of new therapeutic approaches for scabies, and strategies for improving the management of scabies in aged care facilities. Dr Mounsey has a strong commitment to community engagement, research dissemination and translation, particularly in the area of Indigenous Health. In 2011 she was awarded the Northern Territory Young Tall Poppy Scientist of the Year for excellence in research and engagement. She has been actively involved in community based research to improve skin health in Indigenous and other disadvantaged populations.

 Smor

Dr Siobhan Mor  (Australia) 

Dr Siobhan Mor is an interdisciplinary, veterinarian-researcher and epidemiologist. Her research focusses on the epidemiology of zoonotic, emerging and tropical infectious diseases of global health importance, with particular focus on sub-Saharan Africa. Following her veterinary training at The University of Sydney, she completed a PhD in infectious disease epidemiology at Tufts University. Following this she served as global health advisor for a USAID-funded project that aimed to build capacity of developing countries to respond to outbreaks of emerging diseases. She returned to The University of Sydney to assume her current role in 2012. Her work on cryptosporidiosis in humans continues and she now leads a vibrant team of researchers investigating diverse infectious disease topics, including Ebola virus in pigs in Uganda, vector-borne diseases in Maasai cattle in Tanzania, and swine brucellosis in dogs in Australia. Her research has been published in PNAS, Clinical Infectious Diseases and PLoS Neglected Tropical Diseases. 

2012-06-21 06.15.56 

Dr Michael Muleme  (Australia) 

Michael Muleme is a PhD candidate at the University of Melbourne and the Australian Rickettsial Reference Laboratory. His research is focussed on understanding the dynamics of Coxiella burnetii infections in intensively managed goat herds and how they can be used in the design of control strategies to manage the disease on affected properties.

CNourse 

Associate Professor Clare Nourse  (Australia)

Clare Nourse is a Paediatric Infection Specialist at Lady Cilento Children’s Hospital in Brisbane and is Associate Professor in the Faculty of Paediatrics at the University of Queensland. She qualified in medicine in from Trinity College Dublin and trained at Our Lady’s Hospital for Sick Children in Dublin, Royal Children’s Hospital in Melbourne and Mater Children’s Hospital in Brisbane. Her particular interests are in HIV and TB infection in children, health in resource limited countries, particularly in Timor-Leste and staph aureus infection. She travels regularly to Timor Leste and is a board director of Bairo Pite Clinic, a not for profit hospital in Dili, for which she chairs the Medical Advisory Committee.

MORU 

Professor Wirichada Pan-Ngum   (Thailand)

Wirichada Pan-Ngum’s research mainly involves using modelling approaches to gain better understanding of transmission routes of zoonotic diseases and the Human-Animal-Ecosystems interface. Her current work focuses on leptospirosis, one of many long-term health problems for agricultural workers in Thailand. The influence of climate change, and flooding in particular, has caused increased concern for leptospirosis outbreaks. Her model explores the importance of these environmental factors as well as the risk of disease exposure during traditional rice farming activities in relation to the incidence of human leptospirosis. Her other research interests include dengue transmission and spraying strategies, human contact patterns and population dynamics for infectious disease modelling.

In addition to her work at MORU, Wirichada is an Assistant Professor in the Department of Tropical Hygiene, Faculty of Tropical Medicine at Mahidol University. She teaches biostatistics and mathematical modelling. In addition, she serves as a project advisor for postgraduates on the Tropical Medicine and Biomedical and Health Informatics courses.      

 Rayphoto (230x280)

Dr Raymond Pierce (France) 

After obtaining his PhD in biochemistry at the University of London (Queen Elizabeth College) Dr Raymond Pierce moved to France, initially for a Post Doc at the University of Lille, then at the Pasteur Institute of Lille. Since 1982 he has been a tenured CNRS (Centre National de la Recherche Scientifique) scientist mainly working on the molecular biology of schistosomes. His most recent work has concerned gene transcription, and particularly epigenetic regulatory mechanisms. Raymond Pierce currently coordinates an EC-funded collaborative project (A-ParaDDisE) involving research teams in Europe, Australia and Brazil, which aims to develop novel therapeutic agents against schistosomes and other parasites by targeting the enzymes involved in epigenetic processes.

 Mplebanski

Professor Magdalena Plebanski  (Australia)

Professor of Immunology, Monash University MBA, PhD. Howard Hughes International Scholar, USA (2000-2005); Senior Research Fellow NHMRC (current). Prof. Plebanski is internationally recognised for the development of nanotechnology and immuno-therapeutics with application in cancer, infectious diseases and inflammatory lung disease. Prof. Plebanski’s 14 patent families (100 individual patents), supported the formation of three successful biotechnology companies in the UK and in Australia, with product testing in human clinical trials. During this time Prof. Plebanski managed large scale multidisciplinary development teams nationally and internationally in diverse roles scientific advisor, CSO, CEO and Director. Publication History: Career total 129 peer-reviewed papers, citied >5000 times (Scopus), average citations/paper = 42, h-index = 40. Includes Lancet, Science, Nature, Nature Medicine, Nature Biotechnology, Nature Communications, Immunity, PNAS, J. Clin. Invest. Plos Pathogens, Nature Communications. In the last 5 years alone: 43 publications, including Nature Communications 2013, 2015; Lancet 2016.  

 

Professor Gerd Pluschke  (Switzerland)

Professor Gerd Pluschke is Head of the Molecular Immunology Unit of the Swiss Tropical and Public Health Institute (Swiss TPH) in Basel, Switzerland. He obtained a MSc in biochemistry and a PhD at the University of Tübingen and undertook postdoctoral training at the Max-Planck Institute for Molecular Genetics (Berlin) and the Washington University (St. Louis). After working at the Basel Institute for Immunology and for Ciba Pharma Research, he joined the Swiss TPH where he is working on bacterial meningitis, malaria and Mycobacterium ulcerans disease (Buruli ulcer). His research interests are in host-pathogen interactions, molecular epidemiology and vaccine development. Prof. Pluschke is member of the WHO Technical Advisory Group on Buruli ulcer. He is an author of over 200 publications and an inventor on several patents.

 dr-peralam-yegneswaran-prakash

Dr  Peralam Yegneswaran Prakash  (India)

Dr. Peralam Yegneswaran Prakash did Masters in Medical Microbiology from Kasturba Medical College, Manipal. He did doctoral research in Medical Mycology and earned Ph.D in 2012. Currently working as an Associate Professor in Microbiology and In-charge for the Medical Mycology Laboratory Division, Department of Microbiology, KMC, Manipal. He is involved with teaching assignments at Manipal group of institutions both at undergraduate and postgraduate levels for courses in microbiology held at KMC, SOLS, WGSHA, MCODS and MCONS. He has guided undergraduate projects, postgraduate dissertations and been a subject expert member for doctoral thesis. With a specific research interests in the area of medical mycology he is involved with research and has published and presented scientific papers at conferences held in US, Japan, Finland, Thailand, Rome, Singapore, Australia and prestigious national forums in India on Medical Mycology. He had been invited in 2008 as a Guest Researcher at the CDC, Mycotic Diseases Branch, Atlanta, Georgia, USA, and is recipient of Summer Research Fellowship – 2008 jointly conferred by 3 national science academies of India (IAS-INSA-NASI). He received extramural research grants and has been active member of medical mycology associations; Society of Indian Human Animal Mycology (SIHAM), Mycology Society of India (MSI), Asia Pacific Society of Medical Mycology (ASPMM), Asian Mycological Association (AMA), International Society of Human and Animal Mycology (ISHAM), International Mycological Association (IMA), American Society of Microbiology (ASM), Pan African Medical Mycology Society (PAMMS). He has been a Founder member & Young ISHAM representative for India, Sri Lanka, Pakistan, and Bangladesh from 2012. During the 36th annual meeting of Mycological Society of India (MSI) received the Best Mycology paper presentation award – 2009 and in the same year he had been conferred ‘Seed Money to Young Scientists for Research’ [SMYSR] Grant from VGST-DST-GOK. He coordinates as a Resource person national level workshops on ‘Techniques in Diagnostic Mycology’ for Junior faculty members, postgraduate residents, research scholars in India. Dr. Prakash had been Quality Manager – Technical for NABL Accreditation of Microbiology Laboratory during 2008-2009. He is actively involved as a member in the Physician & Scientists of Mycoses Study Group Education & Research Consortium (MSGERC). He is National Training Faculty for the 3T (Train-Teach-Transfer) series of training programs towards implementation of vertically integrated UNESCO Bioethics and member of the International Forum of Teachers (IFT) of the UNESCO Chair in Bioethics and MU-FAIMER (Foundation for Advancement of International Medical Education and Research) Fellow.

 RN Price_web

Dr RN Price  (Australia)

Ric Price is a Wellcome Trust Senior Research Fellow in Clinical Medicine, Professor of Global Health at the Menzies School of Health Research (Darwin, Australia) and Professor of Tropical Medicine at the Centre of Tropical Medicine (University of Oxford, UK). His translational research program focuses on improving the diagnosis and management of multidrug resistant P. falciparum and P. vivax infections. He is head of the clinical module of the WorldWide Antimalarial Resistance Network (WWARN) and the Chair of Vivax Working Group of the Asia Pacific Malaria Elimination Network (APMEN).

 Sima Rafati Photo

Professor Sima Rafati   (Iran)

Sima Rafati is Professor at Pasteur Institute of Iran and head of Immunotherapy and Leishmania Vaccine Research Department. She obtained her Ph.D in the field of Biotechnology and trained as immunologist. Sima has more than 20 years’ experience in experimental vaccine development against cutaneous and visceral leishmaniasis. The very first achievement was identification of cysteine proteinase as novel immunogenic antigen, which was then extensively used as potential vaccine formulations in different animal models such as rodent and dogs. She continued to extend antigen discovery over parasite’s whole genome and also vector’s salivary proteins for further promising immunogenic antigens. The choice of the non-pathogenic to humans L. tarentolae strain as a vaccine vehicle to express parasite or sandfly antigens or a combination of both has revived interest for live vaccination strategies for leishmaniasis. She published over 100 publications in peer reviewed journals with over 2525 Citations.

 ARalph

Dr Anna Ralph  (Australia) 

Dr Ralph is a specialist in Infectious Diseases at the Royal Darwin Hospital; NHMRC Research fellow at the division of Global and Tropical Health, Menzies School of Health Research, Darwin, Australia, and the Clinical Director of RHD Australia. Her research fields include rheumatic fever / rheumatic heart disease (RHD) in Australian Indigenous populations (including diagnostics and health services research), and tuberculosis in neighbouring South-East Asian settings (including clinical trials, epidemiological and diagnostics research).

 Rama

Professor Emeritus Dato’ Dr. C.P. Ramachandran   (Malaysia)

Professor Emeritus Dato’ Dr. C.P. Ramachandran is a pioneer researcher in the field of parasitology, particularly lymphatic filariasis (LF) or Elephantiasis. He obtained a bachelor’s degree in science from the University of Madras. Then, Dr. Ramachandran earned post-graduate degrees in London and Liverpool Schools of Tropical Medicine. He also holds a Doctorate in Medical Science from the University of Tokyo.  He is a Fellow of the London Institute of Biology, the Academy of Medicine of Malaysia and the Academy of Sciences, Malaysia and the Australasian College of Tropical Medicine.  He is also an Honorary Fellow of the UK Royal Society of Tropical Medicine & Hygiene and the Liverpool School of Tropical Medicine and Honorary Professor of the Faculty of Tropical Medicine, Prince Mahidol University, Bangkok.  In addition, he is a founder member and past President of the Malaysian Society of Parasitology and Tropical Medicine. In 2009, he was named ‘Professor Emeritus’ by the University of Science Malaysia, for overseeing a period when the school developed into a major research institution, while he served for ten years as professor and dean of School of Biological Sciences.

LRenia 

Dr Laurent Renia  (Singapore)  

Laurent Renia is currently the executive director of the Singapore Immunology Network (SIgN). Laurent Renia obtained his PhD in 1991 Universite Pierre et Marie Curie in Paris, France where he studied the immune response against the pre-erythrocytic phase of malaria. He continued to work on malaria immunology in New York University (1991-1992). He then returned to Paris in 1993 where he obtained a permanent position as junior research scientist at the French national of Institute of Health (INSERM) working on malaria immunology in the INSERM Unit 313 at the Hopital Pitie-Salpetriere in Paris. He moved to the INSERM Unit 445 at the Institut Cochin in Paris where he started his own group in 1997. Between 2001-2006, he became research director at INSERM, co-director and director of the Department of Immunology at the Institut Cochin.  He joined SIgN in 2007. He holds adjunct Professorships with the Department of Microbiology, Yong Loo Lin School of Medicine at the National University of Singapore, at the School of biological Sciences, Nanyang technological University in Singapore, and is an associated laboratory to the French National Institute of Health (INSERM). He has published more than 200 articles and book chapters. He is an Academic Editor for Infection and Immunity, PLoS ONE, Infection and Immunity, Microbial Pathogenesis and Frontiers in Immunology.

Sally Roberts 

Dr Sally Roberts  (New Zealand)  

Dr Sally Roberts is a graduate of the University of Auckland School of Medicine graduating in 1989. She is a Clinical Microbiologist and Infectious Diseases Physician at Auckland City Hospital and is the Clinical Head of Microbiology at LabPlus, Auckland District Health Board. Her main interests include the diagnosis of infectious diseases and prevention of healthcare-associated infections.She maintains a keen interest in teaching trainees and research having published over 100 articles and book chapters.

 TRomig_web

Dr Thomas Romig  (Germany) IJP Sponsored Speaker 

Thomas Romig is a biologist who has been working with cestode zoonoses in Africa since the early 1980s, when for eight years he was a member of a research team on control of cystic echinococcosis in the Turkana region of Kenya run by the African Medical & Research Foundation. After some years spent with diagnostics of human parasitic diseases at the Technical University of Munich (Germany), he returned to Echinococcus research by running a large-scale field trial to control the sylvatic transmission of E. multilocularis using anthelmintic baits for foxes, based at the University of Hohenheim (Stuttgart, Germany). He co-coordinated two EU-funded consortia on the registration and epidemiology of alveolar echinococcosis across the European Union (1997-2005), worked on aspects of fox biology and did field studies in Japan on control of E. multilocularis for the Hokkaido Institute of Public Health. Currently, he works as a researcher and lecturer at the University of Hohenheim and coordinates the epidemiological aspects of a multinational network on cystic echinococcosis in sub-Saharan Africa (CESSARi), which includes researchers from Sudan, Ethiopia, Kenya, Uganda, Zambia, Namibia and South Africa. Since 2012 he is the 1st vice president of the European Federation of Parasitologists (EFP).

 Darren - HIVFQ crop

Associate Professor Darren Russell  (Australia)

Dr Darren Russell is a sexual health physician and the Director of Sexual Health at Cairns Hospital. He holds the positions of Clinical Associate Professor in the Department of Population Health at The University of Melbourne and Adjunct Associate Professor in the School of Medicine and Dentistry at James Cook University. He is the Chair of the HIV Foundation Queensland and a past-President of the Australasian Chapter of Sexual Health Medicine of the Royal Australasian College of Physicians, the Victorian AIDS Council, and the Australian Federation of AIDS Organisations. Darren is the co-editor of the textbook, ‘Sexual Health Medicine’, and has an interest in Indigenous sexual health and the elimination of HIV and hepatitis C infections.

Saw Saw

Dr Saw Saw  (Myanmar) WHO/TDR Sponsored Speaker

Saw Saw is Deputy Director/Head, Health Systems Research Division, Department of Medical Research, Myanmar. She is a visiting lecturer at Health Behaviour Communication Department, University of Public Health. She gained her PhD in 2007 in Public Health from the University of Melbourne, Australia with funding support of WHO/TDR. She obtained ?Excellent in knowledge transfer award for Doctoral Research? for her PhD thesis from the School of Population Health, University of Melbourne in 2008. Her area of interest is health systems and policy research. She has conducted operational research and implementation research related to TB, Maternal and Reproductive Health, community-based health care and HIV/AIDS in collaboration with service programs. She is the organizer of Structured Operational Research Training Initiative (SORT IT) in Myanmar for National Tuberculosis Programme with support of WHO/TDR Impact Grant. She is actively involved in providing research capacity building for staff of the Myanmar National Tuberculosis Control Program and Maternal and Reproductive Health Program of the Ministry of Health; and other implementing partners. 

MSchemrbi_web 

Professor Mark Schembri  (Australia) 

Professor Mark Schembri is an Australian National Health and Medical Research Council Senior Research Fellow in the School of Chemistry and Molecular Biosciences at the University of Queensland. He is also Deputy Director of the Australian Infectious Diseases Research Centre. His specialist interest is in the area of uropathogenic Escherichia coli, with a focus on the global epidemiology of the multidrug resistant ST131 clone and the molecular genetics of virulence factors associated with infection of the urinary tract. Professor Schembri has published >150 papers and his research has been cited > 6000 times.

 JScott

Dr John Scott  (United States of America)

John Scott, MD, MSc is an Associate Professor of Medicine (Division of Allergy and Infectious Diseases) and the first Medical Director of Telehealth at the University of Washington.  He graduated from Stanford University with a degree in Human Biology, attended Georgetown University School of Medicine cum laude, completed a residency in Internal Medicine at Stanford University Hospitals, and then obtained sub-specialty training in Infectious Diseases at the University of Washington.  He has published in JAMA, Lancet, Hepatology, Clinical Infectious Diseases, Annals of Internal Medicine, Nature Medicine and the Journal of Infectious Diseases. 

In 2013, Dr. Scott spent 4 months at the University of Queensland, Centre for Online Health, learning about the Australian health care system and how telehealth can be used to increase specialty care access and to improve health outcomes.  He was awarded the Best Paper at the 2012 Global Telehealth Conference in Sydney, Australia.  In 2015, he won the Warren Reid Award for excellence in health care for the state of Washington, in recognition of his telehealth work.

In 2009, he launched Project ECHO (Extension for Community Health Outcomes) in Washington State, the first place to replicate the ECHO model outside of New Mexico.  This innovative telehealth program helps clinicians serving in rural and underserved areas with the evaluation and treatment of hepatitis C and has since expanded into the areas of HIV/AIDS, tuberculosis, geriatrics, heart failure, addictions and psychiatry, and multiple sclerosis.  Project ECHO uses case-based learning to increase the capacity of primary care clinicians to care for common, complex diseases. Treatment of patients with hepatitis C through Project ECHO is as safe and effective as in person care (Arora S, et al. NEJM 2011) and is cost-effective.  The Project ECHO model has spread throughout the United States and the world, including to the country of Namibia, a project on which Dr. Scott assisted the CDC.

 DShanks_web

Professor Dennis Shanks  (Australia)

Professor Shanks has been the Director of the Australian Army Malaria Institute (AMI) in Brisbane for the last 10 years and is an adjunct professor at the University of Queensland, School of Population Health as well as James Cook University. For the previous 20 years Prof (then COL) Shanks had been a US Army medical officer who spent the majority of his military career conducting field trials of new antimalarial drugs in the tropics.  His assignments included service at the Walter Reed Army Medical Center, the overseas laboratories of the Walter Reed Army Institute of Research in Thailand and Kenya, and the Australian Army Malaria Research Unit in Ingleburn, Australia (a fore-runner of AMI). Concerned mostly with malaria prevention studies, Prof Shanks has conducted field studies in various rural populations including gold miners in New Guinea, Thai border militia on the Cambodia border, displaced persons in camps along the Thai-Burmese border, tea estate workers of the Kenyan Rift Valley and Kenyan villagers near Lake Victoria.  He performed one of the pivotal efficacy trials for atovaquone proguanil which lead to its licensure as a chemoprophylactic combination and has tested most antimalarial drugs in use today. Most recently he has been using historical data to determine the causes of malaria relapses and mortality during the 1918 influenza pandemic. He has published over 160 research papers on malaria and other infectious diseases. Prof Shanks serves as the medical monitor for several antimalarial clinical trials and is on several advisory committees. His awards include the US Legion of Merit and the John Thompson and Donald MacKay Medals.

 160411_Photo

Dr Amanda Shapiro  (Australia) 

Amanda J. Shapiro is a PhD candidate at the University of Sydney investigating the role of cats and dogs in the transmission of Q fever to humans. Amanda is a veterinarian with experience in companion animal practice as well as within the animal health pharmaceutical industry. Throughout her PhD candidature Amanda has developed broad skills in serological assays, PCR, study design, and survey design. Amanda will submit her thesis in the next few weeks and has five publications. 

 Ricardo Magalhaes

Dr Ricardo J. Soares Magalhães  (Australia)

Dr. Ricardo Soares Magalhaes is a Senior Lecturer in Population Health and Biosecurity at the School of Veterinary Science and Affiliate Senior Lecturer at the UQ Children’s Health Research Centre. He leads the UQ Spatial Epidemiology Laboratory (www.spatialepilab.com) a “One Health” medical geography research group at the University of Queensland, Australia. Ricardo is an infectious disease epidemiologist with qualifications in both human (PhD) and veterinary public health (DVM MSc DiplECVPH). His research program focuses on two main research domains: 1) Development and application of spatial epidemiological methods for infectious diseases of animals and humans and 2) Understanding and quantifying the mechanisms of helminth associated morbidity. His group uses spatial risk assessment tools and social network analysis to investigate the epidemiology of Q-fever, Highly Pathogenic Avian Influenza, Japanese encephalitis and rabies to assist national control programmes to optimize the distribution of disease control strategies. Research at the SpatialEpiLab has also focussed on the mapping of neglected tropical diseases and associated morbidity such as malnutrition, anaemia and childhood development indicators. 

 PMDrSohKimLamJKR_1

Associate Professor Kim Lam Soh  (Malaysia)  WHO/TDR Sponsored Speaker

Dr. Soh Kim Lam is an Associate Professor and the Head of Nursing and Rehabilitation Department at the Faculty of Medicine and Health Sciences, University Putra Malaysia. Since her appointment as the Head of Nursing Unit in 2013, she has focused her efforts and dedicated her time to upgrading the nursing unit into a department. She also introduced a new field of study in nursing at the Master and Ph.D. level at the University Putra Malaysia. She has committed over 15 years of her academic career to creating a positive learning and work experience for students and staff in the Department as well as nurses in the clinical settings. She has work experience in the Intensive Care, High Dependency, and Coronary Care units. Kim’s Ph.D. is focussed on prevention of intensive care complications and the nurses professional practice environment. Kim is also actively involved in research related to intensive care and health care. She has received a number of research grants at the university, national and international level. Kim is currently supervising a number of Master and Ph.D. students. She is the author of more than 30 peer-reviewed papers and numerous conferences. 

 RusselStothard

Professor Russell Stothard  (United Kingdom)  ASP Sponsored Speaker 

Russell Stothard is a medical parasitologist at the Liverpool School of Tropical Medicine with particular focus on the epidemiology and control of medical and veterinary helminths in Africa. His main interest concerns schistosomiasis and its control with large-scale preventive chemotherapy. Most recently he has been active in highlighting the praziquantel treatment needs of young children. Secondary interests include studies on soil-transmitted helminthiasis (STH), other snail-borne diseases and assessing their interplay with malaria. Since November 2014, he has been the Director of COUNTDOWN (www.countdownonntds.org) an implementation research consortium funded by DFID, UK which is exploring expanded access to treatment. A major initiative within COUNTDOWN  is describing the importance of female and male genital schistosomiasis and developing new links within reproductive health services in Ghana and Cameroon. He is also an active blogger (https://countdownonntds.wordpress.com/), regularly uses Twitter (@StothardRuss) and has been Honorary Secretary for the British Society for Parasitology (2011-2016) and the Royal Society of Tropical Medicine and Hygiene (2006-2010). In 2005, Russell was awarded the Bicentenary Medal of the Linnean Society of London for his research studies of urogenital schistosomiasis on Zanzibar.

 leann_200x300

Professor Leann Tilley   (Australia)  IJP Sponsored Speaker 

Leann Tilley is Professor of Biochemistry and Molecular Biology, and Associate Director for Cell and Structural Biology, at the University of Melbourne’s Bio21 Institute. In 2015 Leann was awarded an Australian Research Council Georgina Sweet Australian Laureate Fellowship to apply convergence science approaches to the malaria parasite. The Laureate Program will develop advanced imaging, biometrology, biophysics and computational modeling techniques. It also includes an ambassadorial role to promote women in research. Leann served as Deputy Director/Director of the ARC Centre of Excellence for Coherent X-ray Science (2006-2014). Her work has been recognised by the award of the Bancroft-Mackerras Medal from the Australian Society for Parasitology (2010) and the Beckman Coulter Discovery Award of the Australian Society for Biochemistry and Molecular Biology (2011).

 MTodd_web

Associate Professor Matthew Todd  (Australia)

Matthew Todd was born in Manchester, England. He obtained his PhD in organic chemistry from Cambridge University in 1999, was a Wellcome Trust postdoc at The University of California, Berkeley, a college fellow back at New Hall College, Cambridge University, a lecturer at Queen Mary, University of London and since 2005 has been at the School of Chemistry, The University of Sydney where he is Associate Professor.

His research interests include the development of new ways to make molecules, particularly how to make chiral molecules with new catalysts. He is also interested in making metal complexes that do unusual things when they meet biological molecules or metal ions. His lab motto is “To make the right molecule in the right place at the right time”, and his students are currently trying to work out what this means.

He has a significant interest in open science, and how it may be used to accelerate research, with particular emphasis on open source discovery of new medicines. He founded and currently leads the Open Source Malaria (OSM) consortium. In 2011 he was awarded a NSW Scientist of the Year award in the Emerging Research category for his work in open science and in 2012 the OSM consortium was awarded one of three Wellcome Trust/Google/PLoS Accelerating Science Awards. In 2015 he was a cofounder of the Open Source Pharma Foundation following receipt of a major grant from Tata Trusts, Mumbai. He is on the Editorial Boards of PLoS One, Chemistry Central Journal, ChemistryOpen, Nature Scientific Reports and Nature Scientific Data.

 aprof-andrew-vallely

Dr Andrew Vallely  (Australia)  

Andrew Vallely is a medically-trained epidemiologist who has led multi-disciplinary research teams in developing countries for over 15 years in the epidemiology and prevention of HIV, sexually transmitted and other infectious diseases. From 2010-2015, he was Head of the Sexual and Reproductive Health Unit and Deputy Director of Science at the Papua New Guinea Institute of Medical Research. He currently leads clinical research in sexual and reproductive health at the PNGIMR including the WANTAIM Trial, a cluster randomised crossover trial to evaluate the effectiveness, health system implementation requirements, cost-effectiveness and acceptability of antenatal point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-income settings; and a field trial of point-of-care HPV-DNA testing for cervical cancer screening.  

 Nongnuch Vanittanakom_web

Professor Nongnuch Vanittanakom  (Thailand)

Nongnuch Vanittanakom was DAAD scholarship and received Dr.rer.nat. (cum laude) degree from the Eberhard-Karls-University of Tübingen, Germany in 1985. From 1991 to 1992, she was Alexander von Humboldt Postdoctoral Research Fellow at the Microbial Genetics, Faculty of Biology, Eberhard-Karls-University of Tübingen. In 1994, she was Postdoctoral Research Fellow of the Fogarty National Institute of Health, USA, at the Johns Hopkins University. For her academic career, from 1980 to 1986, she worked at Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok. Since 1987, she moved to work at the Department of Microbiology, Faculty of Medicine, Chiang Mai University. Presently, N. Vanittanakom is a Professor in Microbiology. In February 2016, she received Professor Emeritus Honor from Her Royal Highness Princess Sirindhorn. She is mainly interested in Medical Mycology. She was participated as an invited speaker in several international conferences, for examples, the Congress of the International Society for Human and Animal Mycology (ISHAM), the Asean Conference in Medical Laboratory Technology, the International Conference on Opportunistic Pathogens in AIDS, the International Mycology Congress (IMC) and the International Congress of Mycology (IUMS).

 PC230097cr

Dr Susana Vaz Nery  (Australia) 

Susana Vaz Nery is a Research Fellow at the Research School of population Health, Australian National Universtiy Australia and an adjunct Professor at the School of Medicine, Porto University in Portugal. She coordinates the WASH for Worms trial in Timor-Leste. She has a MSc in Health Policy Planning and Financing (LSHTM, UK) and a PhD in Neuroscience (NYU Medical Center, USA). She is interested in infectious disease epidemiology and public health, with experience in research and development work in Mozambique, Kenya, The Gambia, Tanzania, Angola and Timor-Leste.

Jaco Verweij_web 

Dr Jaco J. Verweij  (The Netherlands)

Jaco J. Verweij earned his PhD degree at Leiden University in the Netherlands on “Molecular tools in the diagnosis of intestinal parasitic infections”. For more than 20 years, he has worked in the department of Parasitology of the Leiden University Medical Center, on the development, validation and implementation of new diagnostic tools, molecular methods in particular. He has a passion for teaching and is a strong advocate for technology transfer and capacity building in the countries suffering the most from parasitic diseases. Since 2012, he holds a position as a medical molecular microbiologist and parasitologist in the Laboratory for Medical Microbiology and Immunology of the St. Elisabeth Hospital in Tilburg, the Netherlands.

 AmandaWAtson

Dr Amanda Watson  (Australia)

Dr. Amanda H. A. Watson is a Visiting Fellow with the State, Society and Governance in Melanesia program, Coral Bell School of Asia Pacific Affairs at Australian National University. Her research focuses on mobile phones in Papua New Guinea. From 2012 to 2016, the research received funding from the Australian government for projects testing the strategic use of mobile telephony in rural development efforts across several sectors including health, education, justice and governance. In the health field, Dr. Watson has published in Australasian Psychiatry and the Journal of Personalized Medicine.

Conall Watson

Dr Conall Watson  (United Kingdom)  Boehringer-Ingelheim Sponsored Speaker

Conall is a specialty registrar in public health at the London School of Hygiene and Tropical Medicine where he researches vaccination against typhoid transmission in collaboration with Pacific partners. In 2014 he was seconded to the Ebola response effort at the World Health Organization in Geneva to do epidemiological planning for potential use of vaccines. He co-designed the novel smallpox-inspired ring vaccination trial which demonstrated high efficacy for the rVSV vaccine at interim analysis. Previously work includes communicable disease surveillance and response at the UK national centre in Colindale, including surveillance preparations for the London Olympics, immunisation policy at the UK Department of Health and clinical and managerial roles in the UK National Health Service. 

NWest_web

Dr Nick West  (Australia)

Dr West is a molecular microbiologist, expert in bacterial pathogenesis. He is Head of “Tuberculosis Research” in the School of Chemistry and Molecular Biosciences, University of Queensland. Dr West has a particular interest in drug development for TB. His research utilises modern molecular technologies to identify the genetic requirements for Mycobacterium tuberculosis to cause Tuberculosis (TB) with these genetic discoveries translated into novel antibiotic therapies. Research within his group falls largely into one of the following three themes: essential gene identification, understanding latency and targeted drug development. Dr West teaches molecular microbiology and microbial pathogenesis.

 MWhittaker_web

Professor Maxine Whittaker  (Australia)

Maxine A. Whittaker, MBBS,  MPH , PhD, FAFPHM is the Dean of the College of Public Health, Medical and Veterinary Sciences at James Cook University (Feb 2016) , and was previously (2008-2016) Professor of International and Tropical  Health and Co-Director of the WHO Collaborating Centre on Health Information Systems, Director of the Health Information Systems Knowledge Hub, Program Director of the Australian Initiative on Control and Elimination of Malaria/Pacific Malaria Initiative Support Centre and co-Secretariat of the Asia Pacific Malaria Elimination Network. Maxine Whittaker is active in scientific research especially in fields of operational and health services research and medical anthropology, with a primary focus on infectious diseases including malaria, One health and sexual and reproductive health, health seeking behaviour and quality of care. She has a special interest in the issue of scaling-up pilot programmes into policy and practice, and as a founding member of Expandnet (http://www.expandnet.net/) has contributed to a body of work published by WHO on this topic. She  is the  Co- Chair of the WHO Research Project Review Panel of the Department of Reproductive Health and Research including the WHO Special Programme Of Research, Development And Research Training In Human Reproduction and remains a member of this Panel. Maxine Whittaker has lived and worked in Bangladesh, Zambia, Zimbabwe and PNG and worked extensively in China, Fiji, Indonesia, Kenya, Philippines, Samoa, Solomon Islands, Tanzania, Thailand , Tonga, Vanuatu, and Vietnam.  She is presently leading the Malaria Elimination Research Agenda work on social sciences and co-chairing the health Systems panel (http://www.malariaeradication.org/malera-refresh) and is recognized as one of the leaders in re-invigorating social sciences and community participations  in the malaria research agenda. She has published more than 70 peer reviewed publications, and several project documents for development partners and countries, policy briefings, briefing papers, book chapters and commissioned papers. 

 WilderSmithAnnelies_200x300

Professor Annelies Wilder-Smith   (Singapore)

Annelies Wilder-Smith is Professor for Infectious Diseases Research at the Lee Kong Chian School of Medicine, Singapore. A world renowned expert in travel and tropical medicine, she is the President of the International Society of Travel Medicine (ISTM), Past-President of the Asia Pacific Society of Travel Medicine, and was Chair of the Regional ISTM Conference in Singapore. Her special research interests include vaccine preventable and emerging infectious diseases, in particular dengue, influenza and meningococcal disease. With a career spanning over two decades, she has led and co-led various clinical trials, published more than 180 scientific papers, edited and co-edited textbooks and travel medicine books, served on various editorial boards and scientific committees, including being editorial consultant to The Lancet. Since 2006, she has been consultant to the World Health Organization and co-editor of the annual WHO publication “International travel and Health”, serving on various committees related to International Health Regulations. Her awards include the Myrone Levine Vaccinology Prize, the Honor Award for exemplary leadership and coordination in determining and communicating global yellow fever risk presented at the CDC Award Ceremony, the Mercator Professorship award by the German Research Foundation and the Ashdown Oration Award by the Australian College of Travel Medicine. She is currently the Principal Investigator of an EU funded international consortium called “DengueTools” (www.denguetools.net) and also Senior Advisor to the Dengue Vaccine Initiative (www.denguevaccines.org).

bw_headshot 

Dr Trent Yarwood  (Australia) 

Trent Yarwood is an infectious diseases physician from Cairns, where he is a visiting medical officer at Cairns Sexual Health and the clincal lead for antimicrobial stewardship at Cairns Hospital.  His clinical interests include the management of medical complications in patients living with HIV and the prevention and control of healthcare-associated infections.  He is the Queensland representative on the Board of Directors for the Australasian Society for HIV, viral hepatitis and sexual health. 

paulyoung

Professor Paul Young  (Australia)

Paul Young is Professor of Virology and Head of the School of Chemistry & Molecular Biosciences at the University of Queensland, Australia. He is the current Vice President of the Virology Division of the International Union of Microbiological Societies. He gained his PhD from the London School of Hygiene & Tropical Medicine in 1986 where he began his research on the dengue viruses. He returned to Australia in 1989 and continued his dengue vaccine development program along with research aimed at understanding the molecular basis of dengue virus induced pathogenesis, improved diagnostics as well as therapeutic control strategies for the flaviviruses, dengue and West Nile and also respiratory syncytial virus.  

 1604872_619544511458558_20229572_n

Dr Peta-Anne Zimmerman  (Australia)

Dr Peta-Anne Zimmerman is an internationally respected clinician, educator and researcher in infection prevention and control. Dr Zimmerman’s experience includes consultancy work with the World Health Organization (WHO), AusAID, the Asian Development Bank (ADB), the Secretariat of the Pacific Communities (SPC), The Albion Centre and as a member of the WHO SARS Response Team. Her expertise has led her to work extensively in South East Asia and the South Pacific, directly on the development of comprehensive infection prevention and control programmes and integration of public health and acute care response in infectious disease emergencies in low and middle income country settings. Peta-Anne is the Convenor of the Australasian College for Infection Prevention and Control (ACIPC) LMI Special Interest Group, ACIPC representative for the Global Outbreak Alert and Response Network (GOARN) and member of the ACIPC Credentialling and Professional Practices (CAPS) Committee.

She is currently a member of faculty within the Griffith Graduate Infection Prevention and Control Program at Griffith University, an associate member of the Menzies Health Institute Queensland, and Visiting Research Fellow at the Department of Infection Control at Gold Coast Hospital and Health Service, Australia.